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Quasi-Experimental Evaluations of Pediatric Health Care: Clinical Practice 
Guidelines and Insurance Coverage 
 
Abstract 
The underlying theme of this dissertation is the effects of clinical and federal 
policy on health, utilization, and expenditures among children and young adults.  In 
Chapter 1, I evaluate the clinical and economic benefits of clinical practice guidelines 
recommending universal cerebrospinal fluid testing in the emergency department for 
febrile infants aged 29-56 days.  Using a difference-in-differences approach and 
administrative data from 31 U.S. children’s hospitals, I find that these guidelines are not 
associated with better clinical outcomes or lower health care spending, suggesting that 
many families of older infants could be spared the stress associated with cerebrospinal 
fluid testing without harm.  The optimal management of older febrile infants in the 
emergency department has been debated for decades, and results from this study have the 
potential to change clinical practice at the hospital level. 
 In Chapter 2, I assess the impact of the Affordable Care Act dependent coverage 
provision on health care utilization, health, and health care expenditures among young 
adults aged 19-25 years.  Using a difference-in-differences analysis of nationally 
representative data, I find that implementation of the provision was associated with 
improved self-reported health and improved financial protection against the costs of 
health care among young adults.  These findings highlight the importance of continued 
efforts to expand insurance coverage in this population. 
In Chapter 3, I investigate whether insurance coverage loss drives differences in 
access and health care utilization between older adolescents and young adults with 
asthma.  I find that young adults with asthma are less likely to have a usual source of 
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care, to use outpatient care, and to fill asthma medication prescriptions compared with 
older adolescents with asthma.  Differences in insurance coverage account for large 
proportions of these differences.  In a longitudinal analysis, I also find that older 
adolescents with asthma who lose insurance coverage as they transition to young 
adulthood are less likely to have a usual source of care.  Taken as a whole, these results 
suggest that insurance coverage plays a crucial role in ensuring access to care and 
encouraging optimal health care utilization patterns for adolescents and young adults with 
asthma.
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Chapter 1: Association between Cerebrospinal Fluid Testing Guidelines and 
Clinical Outcomes among Febrile Infants Aged 29-56 Days 
 
INTRODUCTION 
According to national U.S. clinical practice guidelines (CPGs), infants aged 0-28 
days who present to the emergency department (ED) for evaluation of fever should 
undergo urine, blood, and cerebrospinal fluid (CSF) testing to facilitate prompt diagnosis 
of urinary tract infections, bacteremia/sepsis, and meningitis.
1-3
  However, the 
management of older febrile infants aged 29-56 days in the ED is controversial and has 
been debated in the literature for decades.
4-10
  While there is general agreement that older 
febrile infants should undergo urine and blood testing, no such consensus exists for CSF 
testing.
1,2
  Universal CSF testing for older febrile infants could prevent missed or delayed 
diagnoses of bacterial meningitis, leading to better clinical outcomes and lower health 
care spending.  On the other hand, if providers can accurately identify which older febrile 
infants need CSF testing after considering clinical presentation and results from other 
laboratory testing, universal CSF testing could increase spending without improving 
clinical outcomes.    
Based on well-known but differing criteria to identify febrile infants at low-risk 
for serious bacterial infections, some U.S. children’s hospitals have adopted CPGs 
recommending universal CSF testing in the ED for older febrile infants, while others 
have adopted CPGs recommending selective CSF testing after considering other 
factors.
11
  To date, no study has compared the clinical and economic benefits of these 
approaches.  While randomization would be ideal for causal inference, such an approach 
would be infeasible due to the practical and ethical difficulties of enrolling sufficient 
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numbers of young infants to potentially undergo an invasive procedure like lumbar 
puncture.   
The objective of this study was to evaluate the association between hospital CPGs 
recommending universal CSF testing in the ED for older febrile infants and clinical 
outcomes, as well as the association between these CPGs and health care spending.  We 
used a quasi-experimental approach that exploited the variation in CSF testing 
recommendations among CPGs for older febrile infants at U.S. children’s hospitals.  
Specifically, we examined hospitals with and without CPGs recommending universal 
CSF testing in the ED for older febrile infants and compared the differences in clinical 
outcomes and spending between these hospital groups among older febrile infants to the 
corresponding differences among younger febrile infants.   
METHODS 
Study design 
 We compared 7 hospitals with CPGs recommending universal CSF testing in the 
ED for older febrile infants aged 29-56 days (CPG group) with 24 hospitals without such 
CPGs (control group).  In the control group, 8 hospitals had CPGs recommending 
selective CSF testing in the ED for older febrile infants meeting specific criteria, while 16 
did not have CPGs guiding management of older febrile infants in the ED (de facto 
selective CSF testing).   
We used a difference-in-differences analysis to estimate differences in clinical 
outcomes and spending between comparison groups among older febrile infants that were 
not predicted by the corresponding differences among younger febrile infants.  An 
important advantage of this approach is that it adjusted for differences in patient 
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characteristics between the comparison groups that did not vary with age.  For example, 
even if infants’ severity of illness at presentation differed systematically between the 
CPG and control group, the effect of this confounder would be netted out by our 
comparisons of older versus younger infants, as long as the difference in illness severity 
was the same in both age groups.    
Data source 
 Data for this study were obtained from the 2007-2013 Pediatric Health 
Information System (PHIS), an administrative database containing encounter-level 
information from 45 non-profit, tertiary U.S. children’s hospitals affiliated with the 
Children’s Hospital Association (Overland Park, Kansas, USA).  Participating hospitals 
provide discharge data for inpatient, ED, and observation unit visits, including 
demographic information, International Classification of Diseases, Ninth Revision (ICD-
9) diagnosis codes, ICD-9 procedure codes, and charges for clinical services.
12
  Because 
the PHIS contains de-identified data, the Institutional Review Board of Boston Children’s 
Hospital deemed this study exempt from review.  
Study sample 
We defined older febrile infants as ages 29-56 days and younger febrile infants as 
ages 7-28 days.  We excluded infants ages 0-6 days because of the unique clinical 
circumstances during the immediate perinatal period.
5
  Following other studies, we 
excluded eight of the 45 PHIS hospitals with previously described data quality problems 
or missing data for ED visits.
13
  To assign the remaining hospitals to the CPG and control 
groups, we determined the presence, content, and implementation year of CPGs for older 
febrile infants based on a previously administered survey of ED medical directors at 
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PHIS hospitals.
11
  Of the 37 hospitals in the survey, we excluded four due to non-
response, one due to data quality issues with the spending variable, and one due to 
inaccurate discharge diagnosis information for ED visits, leaving 31 hospitals in the 
sample. 
For each hospital in the sample, we excluded patient data from years before CPGs 
were implemented, if implemented during the study period.  Following this exclusion, 
there were 423,948 discharge records for infants aged 7-56 days who presented to the ED 
of the 31 hospitals.  We excluded 1,257 records with missing billing or discharge 
diagnosis data.  We further excluded 24,136 records with discharge diagnosis codes 
indicating a complex chronic condition
14
 (e.g., congenital heart disease) since febrile 
infants with these conditions often undergo non-standard evaluations in the ED,
13
 
yielding 398,555 potentially eligible records. 
Following previous research on the management of febrile infants, we further 
restricted the sample to records with one of the following four fever-related codes in a 
discharge diagnosis or admission diagnosis field: 780.6 (Fever and other physiologic 
disturbances of temperature regulation), 780.60 (Fever, unspecified), 780.61 (Fever 
presenting with conditions classified elsewhere), and 778.4 (Other disturbances of 
temperature regulation of infant).
3,13
  We also included records with an infection-related 
admission or discharge diagnosis code that predicted  a complete sepsis evaluation (urine, 
blood, and CSF testing) for at least 50% of infants aged 7-28 days (see Appendix 1.1 and 
Appendix Table 1.1 for further details).  Our strategy was based on the assumption that 
complete sepsis evaluations are good proxies for fevers among infants aged 7-28 days.  In 
support of this assumption, previous research indicates that most febrile infants ≤ 28 days 
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old undergo these evaluations in PHIS hospital EDs.
3
  Complete sepsis evaluations are 
less likely to predict fevers among febrile infants aged 29-56 days, who less frequently 
undergo these evaluations.
13
  As such, we did not include these infants when screening 
diagnosis codes.   
In a sensitivity analysis, we restricted the sample to records with one of the four 
fever-specific diagnosis codes in a discharge diagnosis or admission diagnosis field.   In 
other sensitivity analyses, we constructed the sample using infection-related diagnosis 
codes that predicted complete sepsis evaluations for at least 25% or 75% of infants aged 
7-28 days, instead of 50%.    
Study variables 
The clinical outcome was the occurrence of an adverse event, which we defined 
as any of the following during the initial episode of care or during any readmission within 
three days of discharge: in-hospital mortality (based on the PHIS disposition variable); 
central venous catheter placement (based on ICD-9 procedure codes); mechanical 
ventilation (based on charges or ICD-9 procedure codes); extracorporeal membrane 
oxygenation (based on charges or ICD-9 procedure codes); or a medical complication 
(based on ICD-9 discharge diagnosis codes indicating an infectious or vascular 
complication due to medical care, drug reaction, or blood transfusion reaction).  We 
selected these events as potential indicators of complications from bacterial meningitis 
that would expectedly be more prevalent among patients with delayed or missed 
diagnoses of bacterial meningitis.  Although these adverse events could result from many 
other conditions, we would not expect CSF testing to affect the diagnosis and treatment 
of other conditions.  Therefore, our difference-in-difference estimates should reflect 
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effects of universal CSF testing on adverse events secondary to delayed or missed 
diagnoses of bacterial meningitis only. 
We assessed spending associated with the initial episode of care and any 
readmissions beginning within three days of discharge from the initial episode of care.  
To ensure that differences in spending reflected differences in utilization and not prices, 
we analyzed a standardized spending measure that equaled the standardized unit price of 
a clinical service multiplied by the number of units billed, summed over all services.  The 
standardized unit price for each service was based on the median of unit costs (based on 
charge-to-cost ratios) among PHIS hospitals.
15
  We converted standardized spending to 
2013 dollars using the general U.S. Consumer Price Index.
16
  
Statistical analysis 
We used logistic regression to model the occurrence of an adverse event as a 
function of age group (older versus younger febrile infant) and its interaction with CPG 
group status (CPG versus control).  We included an indicator for each hospital (omitting 
a reference hospital) to control for hospital-specific factors common to younger and older 
febrile infants, such as geographic location and the case mix of infants served by the 
hospitals.  Covariates were the patient’s race/ethnicity, gender, primary insurance payer, 
median annual household income by zip code of residence, season of discharge, and 
discharge year.  We used robust variance estimators to account for clustering at the 
hospital level.
17
  
Using a generalized linear model with a log link, we similarly modeled 
standardized spending as a function of the same terms.
18
  To improve interpretability, we 
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retransformed regression estimates to probabilities or dollars using simulation.  Further 
details on the regression models and simulation procedure are available in Appendix 1.2.   
The coefficient of the interaction between age group and CPG group is the 
difference-in-differences estimate, or the mean difference between the CPG and control 
groups among older febrile infants that was not predicted by the corresponding difference 
among younger febrile infants and not explained by any differences in covariates that 
changed with age group.  A positive difference-in-differences estimate would suggest that 
CPGs recommending universal CSF testing for older febrile infants were associated with 
an increase in the outcome, whereas a negative difference-in-differences estimate would 
suggest these CPGs were associated with a decrease in the outcome. 
Our difference-in-differences analysis relied on the assumption that differences in 
adverse events or standardized spending between the CPG and control groups would have 
been the same among older and younger febrile infants in the absence of differences in 
CSF testing recommendations for older febrile infants.  We performed several tests of 
this assumption.  First, we compared differences in observed patient characteristics 
between comparison groups among older febrile infants with the corresponding 
differences among younger febrile infants.  The existence of differences that varied with 
age would suggest potential bias from differences in unobserved characteristics present in 
older febrile infants but not in younger febrile infants.  Second, we assessed whether 
differences between the CPG and control group varied with age for management 
decisions other than CSF testing, including urine testing, blood testing, parenteral 
antibiotic use, and hospitalization.  Additional analyses assessing the validity of the 
study’s underlying assumption are described in Appendix 1.3. 
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Estimates could be biased if the probability of readmission to a non-PHIS hospital 
differed between comparison groups, since any clinical outcomes or spending associated 
with readmissions to a non-PHIS hospital would not be captured by our dataset.  This 
potential bias would be more likely to exist if the practice of selective CSF testing in the 
control group led to fewer hospitalizations and therefore a higher chance of readmission, 
and if PHIS and non-PHIS hospitals frequently shared patients in the same market.  To 
test for this bias, we compared the proportions of hospitalized older febrile infants 
between comparison groups and excluded 14 hospitals located in metropolitan statistical 
areas with at least one other general children’s hospital in a sensitivity analysis.19  The 
excluded hospitals had lower market share than hospitals without nearby competitors 
(Appendix 1.4).  In additional sensitivity analyses, we excluded the 16 hospitals without 
CPGs for older febrile infants from the control group and excluded infants who did not 
undergo any testing during the initial episode of care, since these infants may not have 
been truly febrile.  
We performed analyses using SAS 9.4, Stata 13.0, and R version 3.1.1.  Two-
sided p values < 0.05 were considered significant. 
RESULTS 
Of 82,047 records meeting sample inclusion criteria, we excluded 6.0% due to 
missing covariate data, leaving 77,076 records in the main sample.  When we included 
records with missing covariate data but did not adjust for these covariates in regressions, 
results did not change substantially.  For analyses of spending, we excluded an additional 
3.9% of records due to missing or inaccurate spending data, leaving 74,207 records.   
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The CPG group included 17,949 records (6,747 from younger febrile infants and 
11,202 from older febrile infants), while the control group included 59,127 records 
(22,868 from younger febrile infants and 36,259 from older febrile infants).  Among 
younger febrile infants, CPG and control groups had similar proportions of females and 
infants of Asian or other race/ethnicity; different proportions of infants of Hispanic, 
black, and white race/ethnicity; and different proportions of infants in each category of 
annual median household income by zip code and primary insurance payer (Table 1.1).  
Differences between comparison groups were similar among older and younger febrile 
infants except in two categories of race/ethnicity (Hispanic and black) and primary 
insurance payer (public insurance and self-pay/other).  Although statistically significant, 
the differences between age-related group differences for these characteristics were small 
(< 2.6 percentage points).  
Febrile infant management profiles by age are displayed in Figure 1.1.  The 
proportion of younger febrile infants undergoing CSF testing was higher (p<0.001) in the 
CPG group (68.0%) than in the control group (64.0%) (Table 1.2).  The proportion of 
older febrile infants undergoing CSF testing was higher (p<0.001) in the CPG group 
(64.7%) than in the control group (46.9%), while the proportion of older febrile infants 
hospitalized following the initial ED visit was similar (p=0.30) between the CPG (52.4%) 
and control (51.9%) groups.  For hospitalization, differences between comparison groups 
were similar among older and younger febrile infants.  For urine testing, blood testing, 
and parenteral antibiotic use, the differences between age-related group differences were 
statistically significant but small (< 6.3 percentage points) compared to the corresponding 
difference for CSF testing (14.2 percentage points).    
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Age profiles in adverse events and standardized spending are displayed in Figure 
1.2.  CPGs recommending universal CSF testing in the ED for older febrile infants were 
not associated with significant differences in the probability of adverse events 
(difference-in-differences: +0.36 percentage points; 95% CI -0.14 to 0.88; p=0.18) or 
standardized spending (difference-in-differences: $195; 95% CI -$543 to $991; p=0.63) 
(Table 1.3).  Results from sensitivity analyses did not substantively differ from our main 
analysis (Table 1.4).   
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Table 1.1.  Age-related group differences in demographic characteristics  
 
 
Older febrile  
infants 
(n = 47,461) 
Younger febrile 
infants 
(n = 29,615) 
Age-related group differences 
Demographic 
characteristic (%) 
CPG 
group 
  
Control 
group 
 
CPG 
group 
 
Control 
group 
 
CPG - 
control: 
older 
febrile 
infants
a 
CPG - 
control: 
younger 
febrile 
infants
a 
Difference-
in-
differences
b
 
GENDER
        
Female 44.6 44.4 44.4 44.2 0.2 0.2 0.0 
RACE/ETHNICITY
        
Hispanic 23.7 31.2 21.7 31.1 -7.5* -9.4* 1.9* 
Black (non-Hispanic 
or ethnicity unknown) 
24.5 20.5 26.6 20.9 4.0* 5.7* -1.7* 
Asian (non-Hispanic 
or ethnicity unknown) 
2.5 2.0 2.4 2.3 0.5* 0.1 0.4* 
Other (non-Hispanic 
or ethnicity unknown) 
6.9 7.0 7.4 7.0 -0.1 0.4 -0.5 
White (non-Hispanic 
or ethnicity unknown) 
42.4 39.4 42.0 38.8 3.0* 3.2* -0.2 
MEDIAN ANNUAL 
HOUSEHOLD 
INCOME BY ZIP 
CODE
 
       
$0 to $30,000 26.5 19.9 25.7 19.6 6.6* 6.1* 0.5 
$30,001 to $50,000 52.1 55.3 53.8 55.4 -3.2* -1.6* -1.6 
$50,001 to $70,000 16.3 18.8 15.5 18.7 -2.5* -3.2* 0.7 
> $70,000 5.1 6.0 5.0 6.3 -0.9* -1.3* 0.4 
PRIMARY PAYER
        
Private insurance 37.7 23.6 38.0 24.2 14.1* 13.8* 0.3 
Public insurance 51.5 68.7 52.7 67.3 -17.2* -14.6* -2.6* 
Self-pay or other 10.9 7.8 9.3 8.5 3.1* 0.8* 2.3* 
 
Abbreviations: CPG, clinical practice guideline 
 
*p< 0.05 
 
a
p value was derived from a chi squared test. 
 
b
This column refers to the difference between age-related group differences and equals (CPG - control 
among older febrile infants) - (CPG - control among younger febrile infants).
  
 We fitted logistic regression 
models modeling each characteristic as a function of the indicator of age group (older vs. younger febrile 
infant), the indicator for CPG group (CPG vs. control), and their interaction.  The p value was derived from 
the hypothesis test that the coefficient of the interaction term equaled zero. 
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Table 1.2.  Age-related group differences in management decisions   
 
 
Older febrile 
infants 
 
Younger febrile 
infants 
 
Age-related group differences 
Management 
decision (%) 
CPG 
group 
 
Control 
group 
 
CPG 
group 
 
Control 
group 
 
CPG - control: 
older febrile 
infants
a 
CPG - control: 
younger febrile 
infants
a 
Difference-in-
differences
b
  
Urine testing
c 
75.9 72.0 71.0 69.9 +3.9* +1.1 +2.8* 
Blood testing
 
78.5 75.1 76.1 75.6 +3.4* +0.5 +2.9* 
CSF testing 64.7 46.9 68.0 64.4 +17.8* +3.6* +14.2* 
Parenteral 
antibiotic 
58.8 52.2 72.4 72.1 +6.6* +0.3 +6.3* 
Hospitalization 52.4 51.9 77.4 78.3 +0.5 -0.9 +1.4 
 
Abbreviations: CPG, clinical practice guideline; CSF, cerebrospinal fluid
 
 
*p< 0.05 
 
a
p value was derived from a chi squared test. 
 
b
This column refers to the difference between age-related group differences and equals 
(CPG - control among older febrile infants) - (CPG - control among younger febrile 
infants).
  
 We fitted logistic regression models modeling each characteristic as a function 
of the indicator of age group (older vs. younger febrile infant), the indicator for CPG 
group (CPG vs. control), and their interaction.  The p value was derived from the 
hypothesis test that the coefficient of the interaction term equaled zero. 
 
c
For definitions of management decisions, see Appendix 1.1. 
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Table 1.3.  Unadjusted means of dependent variables and adjusted difference-in-
differences estimates 
 
 Unadjusted means Adjusted difference-in-differences 
estimates 
 Older 
CPG  
Older 
control  
Younger 
CPG  
Younger 
control  
Estimate
a 
 
95% CI
a 
P value
 
Adverse 
events (%) 
2.22 1.84 3.10 3.07 0.36 -0.14, 0.88 0.18 
Standardized 
spending ($) 
4,168 5,027 6,501 8,111 195 -543, 991 0.63 
 
Abbreviations: CPG, clinical practice guideline; CI, confidence interval 
 
a
For adverse events, estimates and 95% confidence intervals were multiplied by 100 and 
represent absolute percentage point differences.  For standardized spending, estimates 
and 95% confidence intervals represent absolute differences in dollars. 
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Table 1.4.  Results from sensitivity analyses 
 Adverse events Standardized spending 
Estimate
a 
 
95% CI
a 
P value
 
Estimate
a 
 
95% CI
a 
P value
 
Use fever-specific diagnosis 
codes to construct a more 
specific, less sensitive sample 
 
0.19 -0.03, 0.45 0.12 14 -626, 662 0.97 
Use diagnosis codes 
predicting a complete sepsis 
evaluation at least 25% of the 
time among infants aged 7-28 
days to construct sample 
0.24 -0.32, 0.88 0.43 259 -521, 1071 0.52 
Use diagnosis codes 
predicting a complete sepsis 
evaluation at least 75% of the 
time among infants aged 7-28 
days to construct sample 
0.15 -0.24, 0.61 0.49 -121 -852, 578 0.74 
Exclude 14 PHIS hospitals 
with other children’s 
hospitals in the same 
metropolitan statistical area 
 
0.40 -0.32, 1.11 0.28 216 -654, 1128 0.64 
Exclude 16 hospitals without 
CPGs for older febrile infants 
from the control group 
 
0.23 -0.46, 0.97 0.52 247 -510, 1061 0.53 
Exclude two hospitals from 
the CPG group that 
demonstrated lower 
compliance with their CPGs 
 
0.27 -0.22, 0.83 0.32 148 -692, 1058 0.74 
Exclude infants who 
underwent no urine, blood, or 
CSF testing 
 
 
0.34 -0.31, 1.07 0.30 -51 -893, 771 0.91 
Abbreviations: CI, confidence interval; CPG, clinical practice guideline; CSF: 
cerebrospinal fluid 
 
a
For adverse events, estimates and 95% confidence intervals were multiplied by 100 and 
represent absolute percentage point differences.  For standardized spending, estimates 
and 95% confidence intervals represent absolute differences in dollars.
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A. 
 
B. 
 
Figure 1.1.  Hospital management profile by age.  Circles represent urine testing, 
squares represent blood testing, and triangles represent cerebrospinal fluid testing.  A) 
CPG group; B) Control group.     
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A.  
 
B. 
 
Figure 1.2.  Adverse events and standardized spending by age in the CPG and 
control groups.  Squares represent the CPG group, and circles represent the control 
group.  A) Adverse events; B) Standardized spending.   
  
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
DISCUSSION 
In this study of 31 large U.S. children’s hospitals, hospital CPGs recommending 
universal CSF testing for older febrile infants were not associated with better clinical 
outcomes or lower spending.  Although CSF testing confers important clinical benefits 
for certain older febrile infants, our findings do not support a clear clinical or economic 
benefit of CPGs recommending CSF testing for all older febrile infants.   
The lack of a significant association between these CPGs and adverse events in 
our study suggests that providers in the control group were able to accurately determine 
which older febrile infants were at high-risk for bacterial meningitis after considering 
clinical and laboratory factors.  In support of this conclusion, previous research showed 
low rates of serious bacterial infections among older febrile infants classified as low-risk 
by the Rochester protocol, which recommends universal urine and blood testing but not 
universal CSF testing for this population.
6,7
  We also did not detect a significant 
association between CPGs recommending universal CSF testing for older febrile infants 
and spending.  However, diagnostic evaluations for febrile infants, particularly lumbar 
punctures, can cause physical and psychological stress to infants and their families.
20
  
The lack of association between these CPGs and improved clinical outcomes suggests 
that many families of older febrile infants could be spared the stress of CSF testing 
without harm. 
Our findings have implications for research on low-value care.  The majority of 
clinical services have both low-value and high-value applications.
21,22
  As noted by the 
Institute of Medicine, a well-evaluated, reliable CPG can reduce low-value applications 
of clinical services.
23
  Our study suggests that CPGs may also encourage low-value 
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applications of services without increasing their high-value applications, highlighting the 
importance of frequently re-evaluating CPG recommendations using the best available 
evidence.  
Although we used a quasi-experimental design to control for unobserved 
differences between comparison groups that did not vary with age, we could not control 
for unobserved differences that did change with age, including severity of illness.  This 
potential source of bias would be more likely, however, if there were differences in 
observed characteristics between comparison groups among older febrile infants that 
were not predicted by the corresponding differences among younger febrile infants.  
While these differences existed for a few characteristics we examined, they were small 
and paled in comparison to the differences for CSF testing. 
Our study has other limitations.  First, our analyses suggested that CPGs 
recommending universal CSF testing were associated with a $195 increase in spending, 
but our analysis lacked sufficient power to detect an increase of this magnitude.  Second, 
estimates could be biased if the likelihood of readmission to a non-PHIS hospital differed 
between older febrile infants in the CPG and control groups.  However, older febrile 
infants in each group were equally likely to be hospitalized following the initial ED visit, 
and results of a sensitivity analysis excluding hospitals with nearby competitors were not 
substantively different from the main results.  Third, we may have underestimated the 
true number of adverse events due to our reliance on administrative data, though we 
would expect this potential bias to affect the comparison groups equally.  Fourth, we 
relied on diagnosis codes to identify infants with fevers.  While this strategy may have 
led to the inclusion of infants without fevers into our sample, results were substantively 
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unchanged in sensitivity analyses using alternative sample identification strategies.  
Finally, our sample was derived from large, tertiary pediatric hospitals.  As such, our 
findings may not generalize to other types of hospitals and primary care settings.   
CONCLUSION 
In this study of U.S. children’s hospitals, CPGs recommending universal CSF 
testing for older febrile infants were not associated with better clinical outcomes or lower 
spending.  These CPGs may encourage applications of CSF testing that are not associated 
with clinical or economic benefits. 
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Chapter 2: Changes in Health and Medical Spending among Young Adults under 
Health Reform 
 
INTRODUCTION 
Beginning on September 23, 2010, the Affordable Care Act (ACA) allowed 
young adults aged 19-25 to remain on their parent’s private health insurance plan until 
age 26.  In contrast to pre-existing state laws that had already extended dependent 
coverage eligibility, the ACA provision applied regardless of place of residence, marital 
status, or student status.  In addition, the provision applied to self-insured employers.  
Existing plans with start dates before September 23, 2010 were exempted from the 
provision, but plans that started on or after this date were subject to the provision.
1,2
 
Prior to implementation of the provision, approximately 32% of all young adults 
aged 19-25 were uninsured, the lowest coverage rate of any age group in the U.S.
3
  
Recent studies indicate that the provision was associated with improvements in insurance 
coverage and health care access in this population.
3-5
  For example, Sommers et al found 
that the dependent coverage provision was associated with a 6.7 percentage point 
increase in the rate of insurance among young adults 19-25 between September 2010 and 
September 2011.  The provision was also associated with a decreased likelihood of 
experiencing cost-related barriers to accessing health care.
3  
 
 A number of important policy questions remain unanswered.  First, it is unclear 
how the provision affected health care utilization among young adults.  An analysis by 
the Health Care Cost Institute found that utilization of outpatient visits, inpatient 
admissions, emergency room visits, and mental health visits increased in 2011-2012 
among young adults aged 19-25 with employer-based insurance, the population most 
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affected by the dependent coverage provision.
6
  In contrast, another study found 
decreased use of the emergency department in New York, California, and Florida 
following implementation of the provision among young adults.
7
  Furthermore, two 
analyses of national data found no association between implementation of the dependent 
coverage provision and utilization of preventive care such as routine checkups or flu 
shots among young adults.
7-9
 
Second, it is unclear whether the provision improved the health of young adults.  
Several analyses of national data have found an association between implementation of 
the provision and improved self-reported overall health among young adults.
9-11
  
However, a study of national trauma registry data did not find changes in trauma-related 
mortality among young adults following implementation of the provision.
12
  To date, no 
study has specifically assessed the effect of the provision on self-reported mental health.
 
 Finally, it is unclear how the provision impacted health care expenditures among 
young adults.  The Health Care Cost Institute analysis suggested that overall expenditures 
in 2011-2012 increased among young adults aged 19-25 with employer-sponsored 
insurance, but it is unclear whether these changes are attributable to the provision due to 
the descriptive nature of this analysis.
6
  Previous research indicates that the provision also 
improved overall financial protection against the costs of medical care among young 
adults, but the measures of financial protection used in these studies had limitations.  
Mulcahy et al found a significant increase in the proportion of non-discretionary 
emergency department visits by young adults covered by private insurance following 
implementation of the provision.  However, the authors could not assess out-of-pocket 
spending or financial protection against the costs of care outside of the emergency 
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department.
13
  Busch et al found that implementation of the provision was associated 
with a small decrease in the proportion of young adults with annual out-of-pocket 
spending greater than $1,500, but this study did not analyze the effects of the provision 
on overall out-of-pocket spending.
14 
  
 
In this study, we assessed the impact of the ACA dependent coverage provision 
on health care utilization, self-reported physical and mental health, health care 
expenditures, and financial protection against health care costs among young adults aged 
19-25.  Based on previous research, we hypothesized that the provision increased use of 
outpatient care, improved self-reported physical and mental health, increased health care 
expenditures, and improved financial protection against health care costs among young 
adults.  
METHODS 
Study design 
 We conducted a difference-in-differences analysis, in which we estimated 
changes associated with the provision by comparing the difference in outcomes between 
the pre-intervention and post-intervention treatment group with the corresponding 
difference in the control group.  We defined the treatment group as adults aged 19-25 and 
the control group as adults aged 26-34.  Individuals in these age groups share many of the 
same health needs and face similar challenges in the health insurance market.  For this 
reason, similar age-based comparisons have been used in other research on the effects of 
the provision.
4,5
  We defined the pre-intervention period as 2002-2009 and the post-
intervention period as 2011-2012, excluding 2010 as a washout period since many 
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existing insurance plans were unaffected by the provision until they renewed on January 
1, 2011.
2
   
Data source 
 We analyzed the 2002-2009 and 2011-2012 Medical Expenditure Panel Survey 
(MEPS), an annual survey conducted by the Agency for Healthcare Research and Quality 
that collects extensive information on health, health care utilization, and health care 
expenditures among the non-institutionalized U.S. civilian population.  The sampling unit 
is the household, and one respondent answers questions on behalf of all other household 
members.  Respondents are interviewed five times over the course of two years.
15  
 
Because the MEPS contains publicly available, de-identified data, the Institutional 
Review Board at Harvard School of Public Health deemed this study exempt from 
review. 
Study sample 
We included all individuals aged 19-34 with positive survey weights in the 2002-
2009 and 2011-2012 MEPS, defining age as estimated age on September 23 of the data 
year.  These individuals provided a total of 69,502 person-years of data.  We excluded 
451 observations (0.64%) due to missing data for covariates (U.S. Census region and/or 
residence in a Metropolitan Statistical Area), leaving a total of 69,051 observations for 
the main sample.  For analyses of self-reported health, we excluded an additional 543 
observations (0.79%) due to missing outcome data.  The principal group of interest, the 
post-intervention treatment group, contained 6,180 observations.   
Study variables 
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 Insurance outcomes were being insured, privately insured, and publicly insured at 
the end of the calendar year.  Utilization outcomes were reporting at least one outpatient 
visit, primary care visit, emergency department visit, hospitalization, and prescription 
medicine fill in the prior 12 months.  We defined an “outpatient visit” as an in-person, 
non-telephone visit to a physician or allied health professional in an office or hospital 
outpatient department.  We defined a “primary care visit” as an outpatient visit to a 
physician with specialty training in internal medicine, family practice, general practice, 
pediatrics, or osteopathy.    
 Health outcomes were reporting excellent versus less-than-excellent physical 
health and reporting excellent versus less-than-excellent mental health.  At the end of 
each survey interview round, respondents rated their physical and mental health on a five-
point scale (1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent); we defined 
excellent health as a mean response over the year greater than 4.5.    
To evaluate changes in health care expenditures, we assessed total annual health 
care expenditures (out-of-pocket plus insurance payments), annual out-of-pocket health 
care expenditures, and the percent of annual health care expenditures paid out-of-pocket 
among individuals with any annual expenditures.  We used the general Consumer Price 
Index to adjust health care expenditures to 2012 levels.
16
   
Statistical Analysis 
 For binary outcomes, we fitted linear probability models predicting the outcome 
as a function of treatment group status (ages 19-25 vs. 26-34), post-intervention year 
status (2011-2012 vs. 2002-2009), and their interaction (the difference-in-differences 
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estimate).  We used linear models to facilitate straightforward interpretation of the 
interaction term, following the recommendations of previous studies.
17
   
 The distribution of health care expenditures in our sample was right-skewed 
because a substantial proportion of individuals had no expenditures.  As such, we 
modeled annual health care expenditures and annual health care out-of-pocket 
expenditures using a two-part generalized linear model.
18
  We first fitted a linear 
regression model predicting the probability of having any annual expenditures, then fitted 
a generalized linear model with a log link and gamma family variance function predicting 
expenditures among individuals with positive annual expenditures.  Similarly, we fitted a 
linear regression model predicting the probability of having any out-of-pocket annual 
expenditures, then fitted a generalized linear model with a log link and Poisson family 
variance function predicting out-of-pocket expenditures among individuals with positive 
out-of-pocket expenditures.  We chose variance functions for generalized linear models 
based on the modified Park test.
18
  To improve the interpretability of results, we 
retransformed estimates from generalized linear models to the dollar scale using a 
simulation procedure (Appendix 2.1).    
In all regressions, we controlled for gender, self-reported race/ethnicity, marital 
status, U.S. Census Region, and residence in a Metropolitan Statistical Area (urban/rural).  
In addition, we adjusted for the complex survey design of the MEPS by using sampling 
weights and robust design-based variance estimators.
19
  In our main analysis, we did not 
control for socioeconomic status indicators such as family income, since this variable 
includes parental income for young adults living with their parents but does not include 
parental income for young adults living independently.  In addition, we did not control 
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for number of years of education because the effects of education on the outcomes of 
interest vary between treatment groups (e.g., having a high school degree is the norm for 
19 year-olds but may predict low socioeconomic status and poor health among 34 year-
olds).   
Our difference-in-differences analysis relied on the assumption that differences in 
outcomes between the treatment and control groups would have been the same before and 
after the 2010 in the absence of the provision.  To evaluate this assumption, we compared 
pre-intervention trends in outcomes between groups by analyzing data from the 2002-
2009 MEPS, fitting linear regression models or two-part models predicting outcomes as a 
function of treatment group status, year, and their interaction.  In addition, we used linear 
regression to assess the existence of differential changes in observed demographic 
characteristics between the treatment and control groups before and after implementation 
of the provision.  Differential changes in observed characteristics over time would 
suggest the possibility of bias from differential changes in unobserved characteristics. 
 We also performed a number of sensitivity analyses.  First, we adjusted for any 
pre-existing diverging trends in regressions by allowing for a differential level and slope 
change in the post-intervention period (see Appendix 2.2 for more details).  Second, we 
assessed whether results changed when we controlled for family income as a percentage 
of the federal poverty level and number of years of education.  Finally, we redefined the 
control group as individuals aged 28-34 on September 23 of the data year, since 26-year 
olds in the 2011 MEPS and 27-year olds in the 2012 MEPS could have become insured 
under the dependent coverage provision when they were age 25.   
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We performed all analyses using SAS version 9.4 (Cary, NC), Stata SE 13.0, and 
R version 3.1.1.  We considered two-sided p-values < 0.05 to indicate statistical 
significance.   
RESULTS 
Of 69,051 observations in the main sample, 38,848 were in the control group and 
30,203 were in the treatment group.  The demographic characteristics of the two groups 
were mostly similar, except the control group had a substantially higher proportion of 
married individuals and slightly higher proportions of females and whites (Table 2.1).   
Figure 2.1 displays graphs of selected outcomes by year among the treatment and 
control groups, including insurance coverage, self-reported physical and mental health, 
annual out-of-pocket health care expenditures, and percent of annual health care 
expenditures paid out-of-pocket.  Compared with the control group, the probability of 
having any health insurance coverage or private insurance coverage at the end of the year 
increased by 7.6 and 8.7 percentage points among young adults aged 19-25 after 
implementation of the provision, respectively (p < 0.001 for both estimates).  However, 
the probability of having public insurance coverage at the end of the year did not 
significantly change (Table 2.2).   
For the five types of utilization examined, the provision was not associated with 
significant changes in the probability of reporting at least one utilization event in the prior 
12 months among young adults aged 19-25, compared with the control group.  Compared 
with the control group, the probability of reporting excellent physical health increased by 
4.9 percentage points among young adults aged 19-25 after implementation of the 
provision (unadjusted pre-intervention mean: 23.3%; p < 0.001).  The probability of 
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reporting excellent mental health increased by 3.9 percentage points (unadjusted pre-
intervention mean: 33.7%; p = 0.005) (Table 2.2).   
The provision was not associated with a significant change in the probability of 
having any annual health care expenditures among young adults aged 19-25, compared 
with the control group.  In addition, the provision was not associated with a statistically 
significant change in total annual health care expenditures among young adults aged 19-
25 with any expenditures, compared with the control group.  Among young adults aged 
19-25 with any out-of-pocket expenditures, annual out-of-pocket expenditures decreased 
$79 per year compared with the control group (p = 0.03).  After implementation of the 
provision, the mean percent of health care expenditures paid out-of-pocket decreased by 
3.7 percentage points among young adults aged 19-25 with any annual expenditures, 
compared with the control group (unadjusted pre-intervention mean: 34.1%; p = 0.001) 
(Table 2.2). 
Treatment and control groups had similar linear pre-intervention trends for all 
outcomes except for self-reported excellent physical health (difference in slope: 0.54 
percentage points per year, p = 0.04) (Table 2.3).  The trend-adjusted difference-in-
differences estimate for this outcome was +1.3 percentage points (p = 0.28) (Table 2.4).  
Though this finding suggests that we may have overestimated the association between the 
provision and self-reported physical health, we note that the positive direction of the 
trend-adjusted estimate still supported our conclusions (see Appendix 2.2 for further 
discussion of the trend-adjusted results).   
There were statistically significant differential changes in several observable 
characteristics such as the percentage of whites, Hispanics, Asians, married individuals, 
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
individuals from the Midwest and South, and individuals living in urban areas (Table 
2.5).  However, the magnitudes of these differential changes were small (< 5.2 percentage 
points), supporting the validity of the underlying assumption of our approach.   In other 
sensitivity analyses, results were substantively unchanged when we controlled for family 
income and education or excluded individuals aged 26-27 from the control group (Table 
2.4).   
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Table 2.1.  Demographic characteristics of the study sample  
 
Demographic characteristic (%) 
Control group  
(n = 38,848) 
Treatment group  
(n = 30,203) 
GENDER   
Female 54.2 51.9 
RACE   
White 42.6 40.5 
Hispanic 33.0 32.7 
Black 15.9 18.6 
Asian 6.2 5.2 
Other 2.3 3.0 
MARITAL STATUS   
Married 54.9 17.1 
REGION   
Northeast 13.7 14.3 
Midwest 19.3 19.2 
South 37.5 38.3 
West 29.4 28.1 
URBAN/RURAL   
Urban 85.9 85.0 
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Table 2.2.  Impact of dependent coverage provision on insurance coverage, utilization, 
self-reported health, overall health care expenditures, and out-of-pocket expenditures   
 
OUTCOME 
 
Treatment group Control group Estimate of Policy Impact 
(Adjusted Difference) 
Pre-
intervention 
mean   
Post-
intervention 
mean 
Pre-
intervention 
mean 
Post-
intervention 
mean 
Estimate
a 
95% CI P value 
Insurance Coverage at 
the End of the Year  
       
Any health insurance  72.5% 70.9% 62.7% 68.9% 7.6 5.0, 10.3 <0.001 
Private insurance 64.6% 61.0% 51.9% 57.2% 8.7 5.8, 11.7 <0.001 
Public insurance 8.7% 11.3% 12.1% 13.5% -1.2 -2.7, 0.3 0.11 
Health Care 
Utilization in the Prior 
12 months 
       
≥ 1 outpatient visit  63.8% 62.8% 57.1% 55.6% -0.7 -3.3, 1.9 0.61 
≥ 1 primary care 
physician visit  
38.4% 36.6% 32.9% 31.7% 0.5 -2.3, 3.3 0.73 
≥ 1 emergency 
department visit  
12.8% 12.5% 15.0% 15.0% 0.3 -1.6, 2.2 0.75 
≥ 1 hospitalization 7.6% 7.7% 6.1% 5.7% -0.7 -1.9, 0.5 0.27 
≥ 1 prescription 
medicine fill   
54.7% 53.4% 49.2% 46.4% -1.7 -4.2, 0.9 0.21 
Self-Reported Health 
Status 
       
Excellent physical 
health 
23.3% 21.5% 26.9% 29.9% 4.9 2.3, 7.4 <0.001 
Excellent mental health  34.9% 33.7% 36.6% 39.4% 3.9 1.2, 6.6 0.005 
Overall Health Care 
Expenditures 
       
Any annual 
expenditures  
77.1% 75.3% 72.2% 70.5% -0.1 -2.2, 2.1 0.95 
Annual expenditures
b
  $3131 $3922 $2417 $2956 -0.014 
 
-0.33, 0.30 
 
0.93 
Out-of-Pocket Health 
Care Expenditures 
       
Any annual out-of-
pocket expenditures 
72.0% 69.0% 65.7% 62.0% -0.9 -3.3, 1.6 0.49 
Annual out-of-pocket 
expenditures
c 
 
$642 $657 $559 $488 -0.16 
 
-0.31, -0.02 0.03 
Percent of expenditures 
paid out-of-pocket
d
 (%) 
31.9% 34.1% 34.4% 32.8% -3.5 -5.8, -1.2 0.003 
 
a
Estimates report the adjusted coefficient of the interaction between post-intervention status and treatment 
group.  For all outcomes other than annual expenditures and annual out-of-pocket expenditures, estimates 
represent absolute percentage point changes.  For continuous expenditure outcomes, estimates have a ratio-
of-ratios interpretation. 
b
Among individuals with non-zero annual expenditures (n=47,402).    
c
Among individuals with non-zero annual out-of-pocket expenditures (n=42,355).    
d
Among individuals with non-zero annual health care expenditures
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Table 2.3.  Comparison of pre-intervention outcome trends in treatment and control 
groups 
 
OUTCOME Estimate
a 
P value 
Insurance Coverage at the End of the Year    
Any health insurance  0.41 0.11 
Private insurance 0.44 0.10 
Public insurance -0.06 0.68 
Health Care Utilization in the Prior 12 months   
≥ 1 outpatient visit  -0.24 0.30 
≥ 1 primary care physician visit  0.08 0.73 
≥ 1 emergency department visit  -0.01 0.94 
≥ 1 hospitalization -0.04 0.71 
≥ 1 prescription medicine fill   -0.07 0.76 
Self-Reported Health Status   
Excellent physical health 0.54 0.04 
Excellent mental health  0.23 0.43 
Overall Health Care Expenditures   
Any annual expenditures  0.20 0.32 
Total annual expenditures 0.00 0.78 
Out-of-Pocket Health Care Expenditures   
Any annual out-of-pocket expenditures 0.04 0.84 
Total annual out-of-pocket expenditures
 
 0.00 0.62 
Percent of expenditures paid out-of-pocket (%) -0.12 0.55 
 
a
Estimates represent the difference in the slopes of pre-intervention outcome trends between treatment and 
control groups.  For all outcomes other than annual expenditures and annual out-of-pocket expenditures, 
estimates represent absolute percentage point changes.  For expenditure outcomes, estimates have a ratio-
of-ratios interpretation. 
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Table 2.4.  Results of sensitivity analyses   
 
OUTCOME 
 
Adjust for pre-existing 
trends 
Control for socioeconomic 
status 
Exclude ages 26-27  
Estimate
a 
95% CI P 
value 
Estimate
a
 95% CI P 
value 
Estimate
a
 95% CI P 
value 
Insurance Coverage 
at End of the Year  
         
Any health insurance  4.7 2.1, 7.4 <0.001 8.2 5.5, 10.9 <0.001 7.5 4.8, 10.3 <0.001 
Private insurance 4.8 2.1, 7.5 <0.001 9.6 6.8, 12.4 <0.001 8.7 5.6, 11.7 <0.001 
Public insurance 2.5 -1.7, 2.2 0.81 -1.6 -3.2, -0.1 0.04 -1.0 -2.7, 0.6 0.20 
Health Care 
Utilization in the 
Prior 12 months 
         
≥ 1 outpatient visit  1.6 -1.1, 4.2 0.25 -0.3 -3.2, 2.6 0.83 -1.1 -3.7, 1.5 0.42 
≥ 1 primary care 
physician visit 
2.0 -0.6, 4.6 0.13 2.4 -0.8, 5.6 0.15 0.3 -2.6, 3.3 0.82 
≥ 1 emergency 
department visit  
1.0 -0.9, 3.0 0.31 0.1 -1.9, 2.2 0.89 -0.5 -2.5, 1.4 0.60 
≥ 1 hospitalization -0.8 -0.2, 0.6 0.27 -0.7 -2.1, 0.8 0.35 -0.9 -2.2, 0.3 0.15 
≥ 1 prescription 
medicine fill   
-0.4 -3.0, 0.2 0.79 -1.4 -4.3, 1.5 0.34 -2.1 -4.8, 0.6 0.13 
Self-Reported 
Health Status 
         
Excellent physical 
health 
1.3 -1.1, 3.7 0.28 6.0 3.1, 8.9 <0.001 5.0 2.3, 7.8 <0.001 
Excellent mental 
health  
1.3 -1.4, 3.9 0.35 4.1 1.0, 7.3 0.01 3.9 0.9, 6.9 0.01 
Overall Health 
Care Expenditures 
         
Any annual 
expenditures  
-0.6 -3.1, 1.8 0.62 -0.2 -2.6, 2.2 0.89 -0.3 -2.5, 1.9 0.80 
Annual 
expenditures
b
  
-0.04 -0.40, 0.32 0.82 -0.08 -0.39, 0.24 0.24 -0.04 -0.38, 0.30 0.82 
Out-of-Pocket 
Health Care 
Expenditures 
         
Any annual out-of-
pocket expenditures 
0.2 -2.4, 2.8 0.13 -0.0 -2.6, 2.6 1.00 -1.2 -3.7, 1.3 0.35 
Annual out-of-
pocket expenditures
c 
 
-0.18 -0.18, -0.17 <0.001 -0.15 -0.33, 0.02 0.08 -0.16 -0.31, -0.02 0.03 
Percent of 
expenditures paid 
out-of-pocket
b
 (%) 
-1.5 -3.6, 0.7 0.19 -3.4 -5.9, -0.9 0.008 -3.8 -6.1, -1.5 0.001 
a
Estimates report the adjusted coefficient of the interaction between post-intervention status and treatment 
group.  For all outcomes other than annual expenditures and annual out-of-pocket expenditures, estimates 
represent absolute percentage point changes.  For continuous expenditure outcomes, estimates have a ratio-
of-ratios interpretation. 
b
Among individuals with non-zero annual expenditures.   
c
Among individuals with non-zero annual out-of-pocket expenditures.   
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Table 2.5.  Differential change in observed demographic characteristics between 
treatment and control groups  
 
Demographic 
characteristic 
(%) 
Pre-
intervention 
control 
Post-
intervention 
control 
Pre-
intervention 
treatment 
Post-
intervention 
treatment 
Difference-
in-
differences
a 
P 
value
a 
GENDER       
Female 54.2 54.3 52.1 51.3 -0.9 0.34 
RACE       
White 44.0 37.7 42.9 32.4 -4.2 <0.001 
Hispanic 33.0 32.9 32.0 35.3 3.4 <0.001 
Black 15.0 18.8 17.5 22.5 1.2 0.08 
Asian 5.6 8.4 4.7 6.7 -0.8 0.05 
Other 2.4 2.1 2.9 3.2 0.5 0.07 
MARITAL 
STATUS 
      
Married 57.1 47.1 18.2 13.4 5.2 <0.001 
REGION       
Northeast 13.3 15.4 13.8 16.2 0.3 0.62 
Midwest 19.2 19.7 19.8 17.4 -2.9 <0.001 
South 38.0 35.8 38.0 39.3 3.4 <0.001 
West 29.5 29.1 28.4 27.1 -0.9 0.31 
URBAN/RURAL       
Urban 85.1 88.5 83.7 89.5 2.4 <0.001 
a
We fitted a linear probability model predicting each characteristic as a function of treatment group status, 
post-intervention period status, and its interaction.  The difference-in-differences estimate and p values 
refer to the coefficient and significance of the interaction term, respectively.   
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Figure 2.1.  Unadjusted Trends in Insurance Coverage, Self-Reported Health, and 
Expenditures among Young Adults.  A) Percent with any health insurance coverage at 
the end of the year;  B) Percent reporting excellent physical health; C) Percent reporting 
excellent mental health; D) Annual out-of-pocket health care expenditures (among 
individuals with any annual out-of-pocket expenditures); E) Percent of annual health care 
expenditures paid out-of-pocket (among individuals with any annual expenditures). 
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Figure 2.1, continued 
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Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
Figure 2.1, continued 
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D.  
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Figure 2.1, continued 
 
E. 
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DISCUSSION 
 Using a nationally representative survey and a quasi-experimental approach, we 
analyzed changes in health care utilization, self-reported health, and health care 
expenditures among young adults aged 19-25 after implementation of the ACA 
dependent coverage provision.  We found that the provision was associated with 
improved self-reported physical and mental health as well as increased financial 
protection against health care costs in this population. 
The improvements in self-reported physical and mental health following 
implementation of the provision are consistent with prior research on the provision as 
well as with research showing improved self-reported health among previously uninsured 
low-income and elderly adults who gained insurance coverage.
9,10,20,21
  Specifically, we 
detected a significant reduction in the proportions of young adults aged 19-25 reporting 
less-than-excellent physical health and less-than-excellent mental health.  The exact 
mechanism of these improvements is unclear.  One possibility is that gaining insurance 
coverage improved young adults’ sense of security and well-being, thus enhancing 
perception of their physical and mental health.  In support of this latter possibility, a 
study examining the effects of gaining Medicaid coverage among low-income adults in 
Oregon showed that improvements in self-reported health occurred almost immediately 
after becoming insured and before any increases in health care utilization.
20
  This finding 
may raise the question of whether the gains in self-reported health in our study reflected 
gains in “actual” health.22  However, previous research suggests that self-reported 
physical health correlates well with objective health measures, while mental health is 
assessed based on self-report.
20,23
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Implementation of the dependent coverage provision was not associated with 
significant changes in annual health care expenditures among young adults aged 19-25 
years, but it was associated with substantial improvements in financial protection against 
medical costs in this population, as evidenced by decreased annual out-of-pocket health 
care expenditures and a decrease in the percent of annual health care expenditures paid 
out-of-pocket.  These findings are consistent with a large body of literature showing 
improved financial protection against medical costs after insurance coverage 
expansions
20
, as well as with research showing a reduction in cost-related access barriers 
and high out-of-pocket spending among young adults after implementation of the 
provision.
3,14
  
Unlike previous studies on the effects of insurance coverage gains among 
previously uninsured low-income and near-elderly adults, we did not find that 
implementation of the dependent coverage provision was associated with significant 
changes in health care utilization among young adults aged 19-25.
20,24
  Due to limited 
statistical power, however, we cannot be certain that there was no change in utilization 
after implementation of the provision.  If the lack of a detected effect represents a true 
null finding, potential explanations include the existence of other access barriers or the 
lack of perceived need to seek health care, the latter of which may be especially relevant 
for our study’s generally healthy population.25  
 There are a number of other limitations to our study.  First, we lacked sufficient 
statistical power to identify which subgroups differentially benefited from the provision.  
Second, we cannot exclude the possibility that other events during the post-intervention 
period differentially affected outcomes in the treatment and control groups.  Most 
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notably, a number of other ACA provisions took effect on September 23, 2010, including 
provisions that prevented insurers from rescinding coverage for individuals when they 
became sick, eliminated lifetime limits on insurance coverage, and required coverage of 
certain types of preventive care.
26 
 However, these provisions applied to both the 
treatment and control groups, and it is unlikely that they had a differential impact large 
enough to explain our findings.  
CONCLUSION 
In this analysis of nationally representative data, we found that implementation of 
the ACA dependent coverage provision was associated with significant improvements in 
self-reported health and financial protection against health care costs among young adults 
aged 19-25.  Our study highlights the importance of expanding insurance coverage in this 
population and adds to a growing literature demonstrating that coverage expansions – 
whether via public or private coverage, and whether among older or younger adults – are 
associated with rapid improvements in financial protection and perceptions of health.  
Future research will be needed to determine whether our findings generalize to young 
adults aged 19-25 years who gain insurance coverage under the ACA through Medicaid 
eligibility expansions and Health Insurance Marketplaces.  
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Chapter 3: Differences in Health Care Access and Utilization between Older 
Adolescents and Young Adults with Asthma 
 
INTRODUCTION 
 As adolescents transition to young adulthood,
 
they often experience changes that 
could affect their health care utilization, including discontinuation of schooling and 
transitions to independent living.
1,2 
 Many young adults also lose health insurance 
coverage.  Medicaid and the Children’s Health Insurance Program (CHIP) cover 
individuals aged 18 and younger in low-income families but generally do not cover 
individuals aged 19 and older unless they are pregnant, are disabled, or have children.
3
  
Furthermore, prior to a recently implemented provision of the Affordable Care Act 
(ACA), private insurance policies in most states did not cover dependents older than age 
18 unless they were full-time students.
3
  Consequently, individuals aged 19-25 had the 
highest uninsurance rate of any age group in 2010.
4
 
Previous research suggests that the health care access and utilization patterns of 
young adults may be suboptimal.
5,6
  Compared to adolescents, young adults use less 
primary care and rely more heavily on emergency departments (EDs) for care.
7
  Whether 
these differences exist between adolescents and young adults with chronic diseases is 
unknown.   
Using nationally representative survey data, we assessed differences in access and 
utilization between older adolescents and young adults with asthma.  Asthma is highly 
prevalent in these age groups,
8,9
 and exacerbations may lead to emergent care when 
asthma is not appropriately managed or when ambulatory care cannot be accessed.
10,11
  
We hypothesized that young adults with asthma are less likely than older adolescents 
with asthma to have a usual source of care, less likely to use primary and preventive care, 
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less likely to fill prescriptions for asthma medications, and more likely to use the ED.  
We also explored potential mediators of these differences, focusing on insurance 
coverage, a factor targeted by recent legislation. 
METHODS 
Data source 
 We analyzed data from the 1999-2009 Medical Expenditure Panel Survey 
(MEPS), a nationally representative panel survey that examines access and utilization in 
the U.S. civilian non-institutionalized population.  Households are interviewed five times 
during the two-year survey period; one respondent answers for the entire household.  A 
parent or adult relative usually provides proxy reports for adolescents and young adults 
living at home.  In contrast, young adults living away at college and independently living 
young adults self-report information.
12
 
Study design 
 In cross-sectional analyses, we compared several measures of access and 
utilization between older adolescents and young adults with asthma.  In longitudinal 
analyses, we tested whether changes in insurance coverage, schooling, or adult presence 
at home predicted changes in these measures among individuals with asthma 
transitioning from adolescence to young adulthood. 
Cross-sectional analysis 
Study population 
 We included participants for whom a current diagnosis of asthma, an asthma-
related utilization event, or an asthma-related disability day was reported.  Using age on 
July 1, we classified participants aged 14-17 as older adolescents and participants aged 
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19-25 as young adults.  We excluded participants aged 18 because age 18 is a transitional 
year during which changes in insurance coverage, schooling, and living situations often 
occur.  Our aim was to compare outcomes before and after the bulk of these transitions 
occurred. 
Study variables 
 Based on respondent reports of access and utilization over the prior 12 months, 
we constructed 8 dichotomous dependent variables for having: 1) a usual source of care; 
2) ≥1 primary care visit; 3) ≥1 preventive visit; 4) ≥1 fill of a short-acting beta agonist 
(SABA) prescription; 5) ≥1 fill of a controller medication prescription; 6) ≥1 ED visit; 7) 
a cost or coverage-related problem accessing medical care; and 8) a cost or coverage-
related problem accessing medications.  For primary care visits, preventive visits, and 
cost or coverage-related access problems, we analyzed data from 2002-2009 because 
these items were not available prior to 2002. 
 We defined a usual source of care as a non-ED facility that participants usually 
visited when they were sick or needed health advice.  We defined a primary care visit as 
an office visit to a physician whose specialty was family practice, general practice, 
internal medicine, osteopathy, or pediatrics.  We defined a preventive visit as a primary 
care visit that respondents classified as a “general checkup.”13  Information on 
prescription fills was collected from respondent reports and pharmacies.
14
  Controller 
medications included inhaled corticosteroids, leukotriene modifiers, and combinations of 
inhaled corticosteroids/long-acting beta agonists.  We defined a cost or coverage-related 
access problem as a delay or inability to receive care due to unaffordability, denial of 
coverage by an insurance company, or refusal of insurance by a physician.
12 
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Statistical analysis 
 To provide readily interpretable estimates in terms of absolute percentage 
differences, we fitted linear models predicting each dichotomous dependent variable as a 
function of age group (young adults vs. older adolescents), age in months (to adjust for 
trends preceding and continuing in young adulthood), race/ethnicity, gender, and survey 
year.  To adjust for geographic variations, we included geographic identifiers at the level 
of metropolitan areas for densely populated areas and states or Census regions for less 
populated areas (based on strata of the MEPS survey design).   
 In separate models, we added the percentage of months spent uninsured in each 
survey year as a covariate to determine the degree to which differences in coverage 
explained differences in access and utilization between age groups.   
Sensitivity analyses 
 We conducted 3 sensitivity analyses.  First, because respondents were not asked if 
household members had a current diagnosis of asthma until 2003, we conducted an 
analysis that restricted our sample to participants classified as having asthma from reports 
of asthma-related utilization events or disability days.  Second, we used logistic instead 
of linear regression models.  Finally, to test whether differences between age groups were 
driven by inconsistencies between proxy and self-reports, we excluded participants who 
self-reported information the entire survey year. 
Longitudinal Analysis 
Study sample 
 For longitudinal analyses examining participants transitioning from adolescence 
to young adulthood, we restricted the sample to participants with asthma who were aged 
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16-19 at the beginning of survey participation and who provided data in both survey 
years. 
Study variables 
 Because the small cohort size limited statistical power, we only analyzed 5 
dichotomous dependent variables: reports of having a usual source of care and reports of 
having ≥1 primary care visit, preventive visit, fill of a SABA prescription, and fill of a 
controller medication prescription in the prior 12 months. 
 For our main predictors of interest, we created 3 variables describing changes in 
insurance coverage, schooling, and adult presence at home (defined as living with a 
parent or adult relative ≥35) between the first and second years of survey participation.  
To assess insurance loss, we subtracted the percentage of months insured in year 2 from 
the percentage of months insured in year 1 and truncated negative differences (due to the 
few who gained coverage) to zero.  Thus, a unit increase in this variable indicated a 
change from continuous insurance coverage in year 1 to continuous uninsurance in year 
2.  To assess discontinued schooling, we constructed a similar variable from student 
status information reported during each interview.  A unit increase in this variable 
indicated a change from continuous full-time schooling in year 1 to no schooling in year 
2.  To assess loss of adult presence at home, we created a similar variable from household 
structure information reported during each interview.  A unit increase in this variable 
indicated a change from continuous adult presence at home in year 1 to continuous 
independent living in year 2.  Student status is not determined for MEPS participants 
under age 17, but we assumed that adolescents aged 16 were full-time students because 
approximately 98% of the national population is enrolled in school at this age.
15 
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Statistical analysis 
 We fitted linear regression models predicting access and utilization as a function 
of survey participation year (first vs. second), changes in insurance coverage, and the 
interaction between these terms (see Appendix 3.1 for model specification).  The 
interactions estimated the differential changes in outcomes associated with coverage 
losses, relative to participants who experienced no coverage loss.  To control for changes 
in schooling and adult presence at home, as well as to assess whether these social factors 
predicted access and utilization, we similarly included these changes and their 
interactions with survey participation year.  Covariates included age at the beginning of 
year 1, race/ethnicity, gender, data year (MEPS panel), Census region, and, within each 
region, whether participants resided in a metropolitan area or not.  
 We performed analyses using SAS version 9.2 (Cary, NC).  We adjusted for the 
complex survey design of the MEPS by employing sampling weights and using robust 
design-based variance estimators.
16
  We considered two-sided p values < 0.05 to indicate 
statistical significance.  The Committee on Human Studies at Harvard Medical School 
deemed this study exempt from review. 
RESULTS 
Cross-sectional analyses 
 After excluding 18 year-olds, 2,485 participants met inclusion criteria for analyses 
of 1999-2009 data, providing 3,469 person-years of data.  2,173 participants met 
inclusion criteria for analyses of 2002-2009 data, providing 2,958 person-years of data.  
For analyses of usual source of care and cost or coverage-related access problems, we 
excluded 0.5%-1.5% of observations due to missing data. 
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 Older adolescents and young adults with asthma differed significantly by 
race/ethnicity, gender, and insurance coverage (Table 3.1).  Figure 3.1 displays adjusted 
age-specific means and fitted regression lines for the 8 outcomes.  Young adults with 
asthma were less likely to have a usual source of care than older adolescents with asthma 
(adjusted means: 65.5% vs. 79.2%; difference: -13.7 percentage points; P<0.001).  In the 
prior 12 months, young adults were less likely to have ≥1 primary care visit (44.4% vs. 
58.3%; difference: -13.9 percentage points; P=0.006) and ≥1 preventive visit (16.6% vs. 
33.7%; difference: -17.1 percentage points; P<0.001).  Young adults were also less likely 
to fill a SABA prescription at least once in the prior 12 months (34.7% vs. 45.3%; 
difference: -10.6 percentage points; P=0.02) but not significantly less likely to fill a 
controller medication prescription at least once in the prior 12 months. 
Young adults with asthma were more likely to have ≥1 ED visit in the prior 12 
months (28.5% vs. 18.5%; difference: +9.7 percentage points; P=0.01).  They were also 
more likely to experience cost or coverage-related problems accessing medical care 
(8.1% vs. 3.3%; difference: +4.9 percentage points; P=0.01) and medications (5.4% vs. 
1.9%; difference: +3.6 percentage points; P=0.04).  Adjusting for differences in insurance 
coverage reduced differences in access and utilization by up to 61.1%, though the 
difference for ED visits did not change substantially (Table 3.2). 
In sensitivity analyses, results of cross-sectional comparisons were not 
substantively changed by restricting the sample to participants for whom an asthma-
related utilization event or disability day was reported, by using logistic instead of linear 
regression, or by excluding participants who self-reported information the entire survey 
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year (see Appendix 3.1 and Appendix 3.2 for additional analyses regarding potential 
response bias). 
Longitudinal analyses 
 For longitudinal analyses of 1999-2009 data, 740 participants met inclusion 
criteria, yielding 1,480 person-years of data.  We excluded at most 3.8% of observations 
due to missing data.  For analyses of 2002-2009 data, 608 participants met inclusion 
criteria, yielding 1,216 person-years of data.  We excluded 2.3% of observations due to 
missing data. 
 There were substantial differences between age groups in insurance coverage, 
schooling, and adult presence at home (Appendix Figure 3.1).  Transitioning from 
continuous insurance coverage in year 1 to continuous uninsurance in year 2 was 
associated with a significant decrease in having a usual source of care in year 2 (change 
relative to no coverage loss: -25.2 percentage points; P=0.003).  Transitioning from 
continuous full-time schooling in year 1 to no schooling in year 2 was associated with 
significant reductions in reports of ≥1 primary care visit (change relative to no change in 
schooling: -21.1 percentage points; P=0.03) and ≥1 preventive care visit (change relative 
to no change in schooling: -21.4 percentage points; P=0.02).  Transitioning from 
continuous adult presence at home in year 1 to continuous independent living in year 2 
was associated with a significant increase in reports of filling a SABA prescription at 
least once (change relative to no loss of adult presence at home: +20.9 percentage points; 
P=0.001) (Table 3.3). 
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Table 3.1.  Demographic characteristics of study sample, MEPS 1999-2009. 
 
Older Adolescents  
(n = 1871) 
Young Adults         
(n = 1598) 
P value
 
Race   <0.001
a
 
Asian/no other race/not Hispanic 2.1% 3.1% 
Black/no other race/not Hispanic 25.1% 22.3% 
Hispanic 24.5% 20.5% 
Other race/not Hispanic 48.4% 54.1% 
Gender   <0.001
a
 
Female 47.0% 61.6% 
Insurance coverage   <0.001
b
 
 Percent of months uninsured 10.6%  33.5% 
a
P value is derived from a chi squared test. 
b
P value is derived from a two-sample t-test assuming unequal variance. 
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Table 3.2.  Differences in access and utilization between older adolescents and young 
adults with asthma, before and after adjustment for insurance coverage.
 
 
 Absolute 
difference 
between age 
groups, not 
adjusting for 
insurance 
coverage 
(percentage 
points)
 
P value Absolute 
difference 
between age 
groups, 
adjusting for  
insurance 
coverage  
(percentage 
points) 
P value Percent change 
in absolute 
difference 
between age 
groups after 
adjusting for 
insurance 
coverage (%) 
Usual source of care 
 
  
-13.7 <0.001 -8.5 0.02 38.0 
≥1 primary care visit  
 
 
-13.9 0.006 -9.4 0.07 32.4 
≥1 preventive visit 
 
 
-17.1 <0.001 -15.0 0.001 12.3 
≥1 fill of a short-
acting beta agonist 
prescription 
-10.6 0.02 -9.0 0.05 15.1 
≥1 fill of a controller 
medication 
prescription 
-5.3 0.19 -3.7 0.37 30.2 
≥1 emergency 
department visit  
 
9.7 0.01 8.7 0.03 10.3 
Cost or coverage-
related problem 
accessing medical 
care 
4.9 0.01 2.6 0.14 46.9 
Cost or coverage-
related problem 
accessing 
medications 
3.6 0.04 1.4 0.42 61.1 
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Table 3.3.  Changes in health care access and utilization associated with changes in 
insurance coverage, schooling, and adult presence at home, among participants with 
asthma transitioning to young adulthood. 
 
Year 2 – Year 
1 absolute 
change in 
access or 
utilization 
measure 
 
Access or utilization measure (percentage points) 
Usual source of   
care 
≥1 primary 
care  visit 
≥1 preventive      
visit 
≥1 fill of a 
short-acting 
beta agonist 
prescription 
≥1 fill of a 
controller 
medication 
prescription 
Estimate 
P 
value Estimate 
P 
value Estimate 
P 
Value Estimate 
P 
value Estimate 
P 
value 
A. Participants 
with no 
change in 
insurance 
coverage, 
schooling, or 
adult presence 
at home 
0.7 0.76 -5.1 0.12 3.4 0.41 -7.0 0.006 -2.2 0.29 
B. Differential 
change for 
participants 
losing 
insurance 
coverage (vs. 
A)  
-25.2 0.003 -9.0 0.30 -3.7 0.67 -2.3 0.78 -1.1 0.83 
C. Differential 
change for 
participants 
discontinuing 
schooling (vs. 
A)   
1.0 0.89 -21.1 0.03 -21.4 0.02 -10.2 0.16 -10.2 0.07 
D. Differential 
change for 
participants 
losing adult 
presence at 
home (vs. A)   
2.8 0.72 -2.1 0.83 -10.4 0.35 20.9 0.001 4.0 0.42 
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Figure 3.1.  Health care access and utilization among older adolescents and young 
adults with asthma.  Panels A-H display age-specific means and fitted regression lines 
for each of the 8 dependent variables in cross-sectional comparisons. The square data 
points represent excluded data for participants aged 18.  A) Usual source of care; B) ≥1 
primary care visit in the prior 12 months; C) ≥1 preventive visit in the prior 12 months; 
D) ≥1 fill of a short-acting beta agonist prescription in the prior 12 months; E) ≥1 fill of a 
controller medication prescription in the prior 12 months; F) ≥1 emergency department 
visit in the prior 12 months; G) Cost or coverage-related problem accessing medical care 
in the prior 12 months; H) Cost or coverage-related problem accessing medications in the 
prior 12 months.   
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Figure 3.1, continued 
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Figure 3.1, continued 
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Figure 3.1, continued 
 
G. 
 
H. 
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DISCUSSION 
 In this nationally representative study, young adults with asthma were less likely 
than older adolescents with asthma to have a usual source of care and less likely to use 
primary or preventive care.  These findings suggest that young adults with asthma have 
worse health care access and receive suboptimal care, as national guidelines recommend 
that young adults with asthma be seen at least every 6 months to monitor control.
11
  
Young adults with asthma were also less likely to fill SABA prescriptions and more 
likely to experience cost and coverage-related access problems.  Most of these 
differences were reduced substantially after adjusting for differences in insurance 
coverage. 
 In addition, young adults with asthma were more likely to visit EDs, consistent 
with previous research demonstrating that young adults in general rely on EDs for care 
more than adolescents.
8
  Our findings suggest a possible substitution of ED care for 
primary care by young adults with asthma.  Such a substitution would be economically 
inefficient because ED care is more expensive than office-based care for similar 
conditions,
17
 as well as clinically important if the substitution resulted from poor disease 
control or led to poorly coordinated care. 
 Differences in insurance coverage between age groups did not explain the higher 
ED use by young adults with asthma.  This finding suggests that other factors were 
involved or that insurance coverage has offsetting effects on non-emergent and emergent 
ED use in this population.  Previous research examining the role of insurance coverage in 
ED use has produced mixed results.
18
  In one quasi-experimental study, coverage losses 
at age 19 were associated with decreased overall ED use among young adults.
19
  In 
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another study, however, individuals who gained Medicaid coverage through a lottery in 
Oregon did not significantly increase their ED use.
20
  The effects of insurance coverage 
on emergent and non-emergent ED use by young adults are unclear. 
 In longitudinal analyses of participants with asthma transitioning from 
adolescence to young adulthood, becoming uninsured strongly predicted losing a usual 
source of care.  This finding is consistent with a prior cross-sectional study demonstrating 
that uninsured young adults are less likely to have a usual source of care than their 
insured counterparts.
21
  Becoming uninsured was also associated with a large decrease in 
primary care visits, though this change was not statistically significant.  
Discontinuing schooling was associated with decreased use of primary and 
preventive care, while transitioning to independent living was associated with greater fills 
of SABA prescriptions.  There are several potential explanations for these findings.  Non-
students may face greater time costs when accessing primary and preventive care than 
full-time students, who are more likely to have convenient access to student health 
services.
22
  Previous research suggests that familial support improves asthma control in 
adolescents.
23
 As such, it is possible that individuals with asthma develop worse disease 
control after moving away from their families, leading to greater SABA inhaler use.  Due 
to a lack of data on such mediators, however, we could not empirically test these 
potential explanations. 
 Our study has several other limitations.  First, we could not examine ED visits for 
asthma exacerbations or otherwise measure asthma control.  Second, we excluded 
participants aged 18 from cross-sectional analyses because many transitions in insurance, 
schooling, and living situations occur at this age.  However, these transitions could have 
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occurred earlier or later for any given participant.  Third, inconsistencies between proxy 
and self-reports may have contributed to reported differences in access and utilization 
between age groups.  However, our cross-sectional results did not substantively change 
when we excluded older participants who consistently self-reported information because 
they no longer lived with their families.  Thus, any reporting bias was likely small, 
consistent with previous studies demonstrating high concordance between parent and 
adolescent reports of asthma-related office visits, ED visits, and medication use.
24,25 
 Finally, we did not adjust our comparisons for socioeconomic status because of 
inconsistencies in the meaning of household income information across age groups.  
Specifically, for participants living with their parents and unmarried college students 
living away from home, household income information collected by the survey usually 
refers to parental income.  For young adults living independently, however, this 
information represents the young adult’s income. 
 Our findings have important clinical implications.  Many adolescents with asthma 
may experience disruptions in care as they become young adults, with potentially 
deleterious clinical consequences.  Disruptions may be particularly pronounced for 
adolescents with asthma who lose insurance coverage, discontinue schooling, and move 
away from home.  For these patients, pediatric clinicians could implement comprehensive 
plans to facilitate smooth transitions to adult care.
26 
 Our findings also have important policy implications.  The ACA allows 
dependent children to remain on private family policies until age 26 and will expand 
Medicaid eligibility to childless adults with incomes up to 133% of the federal poverty 
level starting in 2014.
3
  Thus, as the ACA is implemented, the number of uninsured 
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young adults will likely fall dramatically.  Our study suggests that these coverage 
expansions may substantially improve access to care for young adults with asthma.  
Indeed, implementation of the ACA dependent coverage provision in 2010 has already 
been associated with modest reductions in uninsurance among young adults,
4,27
 and 
similar state laws in 2005-2006 were associated with improved access among young 
adults.
28
  Our study also suggests that expanding coverage may improve care for young 
adults with asthma.  Adjusting for differences in insurance coverage in this population 
explained 32% of their lower use of primary care and 47-61% of their greater problems 
accessing medical care or medications due to cost or coverage issues. 
Differences in insurance coverage, however, did not fully explain differences in 
access or use of recommended care between adolescents and young adults with asthma.  
We identified other social factors that may contribute to differences in primary and 
preventive care use.  In addition, differences in coverage did not substantially explain the 
higher ED use among young adults with asthma.  These findings suggest that coverage 
expansions supported by the ACA might not fully address suboptimal utilization patterns 
among young adults with asthma. 
CONCLUSION 
 Compared to older adolescents with asthma, young adults with asthma have worse 
health care access and may use care less optimally.  Although losing insurance coverage 
may contribute to these differences, other social factors may also play important roles. 
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Appendix 1.1.  Definitions of management decisions  
 
1) Urine test: urine culture
a
 or a urine test with one of the following descriptions: 
 
Microscopic examination of urine 
Urinalysis, unspecified 
Chemical examination of urine 
Complete urinalysis 
Macroscopic urinalysis 
Other specified urinalysis 
 
2) Blood test: blood culture or a blood test with one of the following descriptions: 
 
Complete blood count, unspecified 
Complete blood count with differential 
Complete blood count without differential 
 
3) CSF test: CSF culture, presence of a charge for lumbar puncture, or a CSF test with 
one of the following descriptions: 
 
Glucose 
Total protein 
Hematology exam, other body fluid   
Microbial identification, nucleic acid probe 
Microbial identification, nucleic acid probe with amplification 
 
4) Parenteral antibiotic: any antibiotic administered intravenously or intramuscularly 
 
5) Hospitalization: admission to the observation unit or inpatient setting 
 
aWe defined a “culture” as a lab test with one of the following descriptions: 
 
Bacterial cultures, unspecified 
Aerobic culture 
Culture with antimicrobial removal device 
Anaerobic culture 
Aerobic and anaerobic culture 
Other specified bacterial culture 
  
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
Appendix 1.2.  Regression specification and simulation procedure for transforming 
difference-in-differences estimates  
 
Regression specification 
We estimated the following generalized linear model (GLM): 
g[E(Yij)]=β0+β1 Olderi +β2 Olderi*CPGj + β3Hospitalfixedeffectsj + 
β4 Covariatesi 
In this model, E(Yij) is the expected outcome (adverse events or standardized 
spending) for infant i in hospital j, Olderi is an indicator of age group (older versus 
younger febrile infant), CPGj is an indicator of CPG group (CPG versus control), and g is 
the link function.  For models of adverse events, we used a logit link (logistic regression); 
for models of standardized spending, we used a log link and a gamma family variance 
function based on the modified Park test.
18
  We included hospital fixed effects (i.e. 
indicators for each hospital, omitting one hospital) to control for hospital-specific factors 
common to younger and older febrile infants, such as geographic location and the case 
mix of infants served by the hospitals.  
Simulation procedure for transforming difference-in-differences estimates 
GLM with logit link: adverse events 
After fitting a generalized linear model predicting the log odds of an adverse 
event, we set the vectors of coefficients and standard errors from the model to the 
parameters of a multivariate normal distribution.  In each of 1,000 simulation loops, we 
sampled coefficient values from this distribution and used these values to calculate the 
fitted values for each observation when 1) the indicator for age group was set to 1 (older 
infant) and the interaction term was set to 1, holding all other covariates constant; and 2) 
when the indicator for age group was set to 1 and the interaction term was set to 0, 
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holding all other covariates constant.  We transformed these fitted values to the 
probability scale using the inverse logit function, then calculated their difference.  The 
average of these differences over all observations in the sample was the estimate of the 
difference-in-differences effect for that simulation loop.  The mean and standard 
deviation of the 1,000 simulation estimates were the point estimate and standard error of 
the difference-in-differences estimate, respectively.  We calculated the p value based on a 
two-sided t-test with 999 degrees of freedom. 
GLM with log link: standardized spending 
 The simulation procedure was identical, except that we transformed fitted values 
to the dollar scale using exponentiation. 
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Appendix 1.3.  Assessing for diverging trends among younger febrile infants 
 
We tested whether differences in adverse events or standardized spending 
between comparison groups changed with increasing age among younger febrile infants.  
After restricting the sample to younger febrile infants, we fitted generalized linear models 
predicting adverse events or standardized spending as a function of age in days, the 
indicator of CPG group status (CPG vs. control), and their interaction.  Analyses were 
adjusted for covariates and used robust variance estimators to account for clustering at 
the hospital level.  Among younger febrile infants, age trends diverged slightly, though 
not significantly, for adverse events (p=0.87) and standardized spending (p=0.11).   
One potential explanation for the slight divergence in trends among younger 
febrile infants is the existence of differences in case mix between comparison groups 
evolving with age.  However, results were not substantively different from the main 
results when we adjusted for pre-existing trends, suggesting that any evolving differences 
in case mix were likely small.   
The other explanation is that physicians in the control group may have deferred 
CSF testing for well-appearing febrile infants with reassuring urine and blood test results 
if these infants were close to the 29-day threshold.  These anticipatory changes in practice 
were suggested by the small decrease in CSF testing among younger febrile infants aged 
21-28 days in the control group and the lack of such a decrease in the CPG group.  If 
present, the anticipatory changes could unmask existing case mix differences between 
comparison groups among younger febrile infants.  However, results were not 
substantively different when we excluded febrile infants aged 21-28 days from the 
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sample, suggesting that any bias secondary to anticipatory changes in practice was likely 
minimal. 
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Appendix 1.4.  Details of sensitivity analysis excluding hospitals with competitors in the 
same metropolitan statistical area 
 
 Using information from the website of the Children’s Hospital Association, we 
identified 14 PHIS hospitals in our sample that were located in metropolitan statistical 
areas with at least one other general children’s hospital.  We did not count rehabilitation 
hospitals or specialty hospitals like Shriner’s Hospitals, as these hospitals do not take care 
of febrile infants.  None of the competitor hospitals were one of the other 31 PHIS 
hospitals included in our sample.  In a sensitivity analysis, we excluded the 14 PHIS 
hospitals with nearby competitors, hypothesizing that febrile infants initially presenting 
to these hospitals were more likely to be readmitted to a competing hospital (thereby 
causing a data capture issue) than febrile infants initially presenting to PHIS hospitals 
without nearby competitors.    
We also assessed whether having a nearby competitor is a reasonable proxy for 
low market share.  For this analysis, we examined the 2009 Kids’ Inpatient Database 
(KID), a national sample of U.S. pediatric hospitalizations that is part of the family of 
databases from the Healthcare Cost and Utilization Project (U.S. Agency for Healthcare 
Research and Quality).  We were able to identify 17 of the 31 PHIS hospitals in our 
sample based on American Hospital Association identifiers; we excluded three of these 
hospitals with missing data for age in months in the KID.  We estimated the market share 
of each of the remaining hospitals by dividing the weighted number of non-birth inpatient 
admissions for infants less than two months of age at the hospital by the weighted total 
number of such admissions in the hospital’s metropolitan statistical area.  In this analysis, 
there were seven hospitals with nearby competitors; market share ranged from 18.1% to 
66.3% with a median of 45.1%.  There were seven hospitals without nearby competitors; 
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market share ranged from 54.7% to 90.1% with a median of 77.5%.  These findings 
suggested that PHIS hospitals with nearby competitors do have lower market share than 
hospitals without nearby competitors, providing support for our approach. 
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Appendix Table 1.1.  ICD-9 diagnosis codes used to construct sample 
 
Code Title Percent of 
infants aged 7-
28 days with 
diagnosis code 
in discharge 
record who 
underwent a 
complete sepsis 
evaluation 
Number of 
infants aged 
7-28 days 
with 
diagnosis 
code in 
discharge 
record 
027.0 Listeriosis 100 13 
711.01 Pyogenic arthritis, shoulder region 100 10 
320.7 Meningitis in other bacterial diseases classified elsewhere 100 9 
382.01 Acute suppurative otitis media with spontaneous rupture of 
eardrum 
100 6 
V09.81 Infection with microorganisms resistant to other specified 
drugs with resistance to multiple drugs 
100 6 
038.8 Other specified septicemias 100 5 
320.1 Pneumococcal meningitis 100 4 
730.22 Unspecified osteomyelitis, upper arm 100 4 
040.41 Infant botulism 100 3 
051.2 Contagious pustular dermatitis 100 3 
079.1 ECHO virus infection in conditions classified elsewhere and 100 3 
098.0 Gonococcal infection (acute) of lower genitourinary tract 100 3 
320.81 Meningitis due to anaerobic bacteria 100 3 
484.8 Pneumonia in other infectious diseases classified elsewhere 100 3 
997.31 Ventilator associated pneumonia 100 3 
003.8 Other specified salmonella infections 100 2 
008.63 Enteritis due to Norwalk virus 100 2 
036.0 Meningococcal meningitis 100 2 
041.82 Bacterial infection due to Bacteroides fragilis 100 2 
047.1 Meningitis due to ECHO virus 100 2 
049.1 Non-arthropod borne meningitis due to adenovirus 100 2 
049.8 Other specified non-arthropod-borne viral diseases of central 
nervous system 
100 2 
070.59 Other specified viral hepatitis without mention of hepatic 
coma 
100 2 
112.4 Candidiasis of lung 100 2 
360.19 Other endophthalmitis 100 2 
384.20 Perforation of tympanic membrane, unspecified 100 2 
478.24 Retropharyngeal abscess 100 2 
482.31 Pneumonia due to Streptococcus, group A 100 2 
482.39 Pneumonia due to other Streptococcus 100 2 
485 Bronchopneumonia, organism unspecified 100 2 
488.0 Influenza due to identified avian influenza virus 100 2 
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Appendix Table 1.1, continued 
 
680.0 Carbuncle and furuncle of face 100 2 
729.4 Fasciitis, unspecified 100 2 
730.02 Acute osteomyelitis, upper arm 100 2 
730.21 Unspecified osteomyelitis, shoulder region 100 2 
730.24 Unspecified osteomyelitis, hand 100 2 
999.33 Local infection due to central venous catheter 100 2 
003.21 Salmonella meningitis 100 1 
004.3 Shigella sonnei 100 1 
008.00 Intestinal infection due to unspecified E. coli 100 1 
008.3 Intestinal infection due to Proteus (mirabilis) (morganii) 100 1 
008.44 Intestinal infection due to Yersinia enterocolitica 100 1 
035 Erysipelas 100 1 
036.89 Other specified meningococcal infections 100 1 
036.9 Meningococcal infection, unspecified 100 1 
038.3 Septicemia due to anaerobes 100 1 
038.44 Septicemia due to Serratia 100 1 
040.82 Toxic shock syndrome 100 1 
041.86 Helicobacter pylori [H. pylori] infection 100 1 
053.0 Herpes zoster with meningitis 100 1 
053.20 Herpes zoster dermatitis of eyelid 100 1 
053.21 Herpes zoster keratoconjunctivitis 100 1 
054.0 Eczema herpeticum 100 1 
054.13 Herpetic infection of penis 100 1 
054.40 Herpes simplex with unspecified ophthalmic complication 100 1 
054.41 Herpes simplex dermatitis of eyelid 100 1 
054.6 Herpetic whitlow 100 1 
058.89 Other human herpesvirus infection 100 1 
078.88 Other specified diseases due to Chlamydiae 100 1 
079.4 Human papillomavirus infection in conditions classified 
elsewhere and of unspecified site 
100 1 
093.89 Other specified cardiovascular syphilis 100 1 
094.2 Syphilitic meningitis 100 1 
099.9 Venereal disease, unspecified 100 1 
322.2 Chronic meningitis 100 1 
323.01 Encephalitis and encephalomyelitis in viral diseases 
classified elsewhere 
100 1 
324.1 Intraspinal abscess 100 1 
360.01 Acute endophthalmitis 100 1 
380.13 Other acute infections of external ear 100 1 
381.02 Acute mucoid otitis media 100 1 
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Appendix Table 1.1, continued 
 
382.3 Unspecified chronic suppurative otitis media 100 1 
383.1 Chronic mastoiditis 100 1 
473.2 Chronic ethmoidal sinusitis 100 1 
473.8 Other chronic sinusitis 100 1 
478.22 Parapharyngeal abscess 100 1 
482.1 Pneumonia due to Pseudomonas 100 1 
484.7 Pneumonia in other systemic mycoses 100 1 
488.09 Influenza due to identified avian influenza virus with other 
manifestations 
100 1 
488.19 Influenza due to identified novel H1N1 influenza virus with 
other manifestations 
100 1 
488.81 Influenza due to identified novel influenza A virus with 
pneumonia 
100 1 
488.89 Influenza due to identified novel influenza A virus with other 
mani 
100 1 
492.8 Other emphysema 100 1 
511.1 Pleurisy with effusion, with mention of a bacterial cause ot 100 1 
519.01 Infection of tracheostomy 100 1 
528.3 Cellulitis and abscess of oral soft tissues 100 1 
730.03 Acute osteomyelitis, forearm 100 1 
730.13 Chronic osteomyelitis, forearm 100 1 
730.15 Chronic osteomyelitis, pelvic region and thigh 100 1 
730.36 Periostitis, without mention of osteomyelitis, lower leg 100 1 
996.68 Infection and inflammatory reaction due to peritoneal 
dialysis catheter 
100 1 
V09.4 Infection with microorganisms resistant to aminoglycosides 100 1 
V09.50 Infection with microorganisms resistant to quinolones and 
fluoroquinolones without mention of resistance to multiple 
quinolones and fluoroquinolones 
100 1 
054.79 Herpes simplex with other specified complications 92.9 14 
590.10 Acute pyelonephritis without lesion of renal medullary 
necrosis 
92.6 136 
047.9 Unspecified viral meningitis 90.1 717 
048 Other enterovirus diseases of central nervous system 90 20 
488.1 Influenza due to identified novel H1N1 influenza virus 89.5 19 
047.8 Other specified viral meningitis 89 848 
038.42 Septicemia due to Escherichia coli [E. coli] 87.5 8 
054.5 Herpetic septicemia 87.5 8 
320.3 Staphylococcal meningitis 87.5 8 
054.43 Herpes simplex disciform keratitis 86.7 15 
320.89 Meningitis due to other specified bacteria 86.7 15 
780.61 Fever presenting with conditions classified elsewhere 86.4 147 
320.2 Streptococcal meningitis 85.9 99 
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054.2 Herpetic gingivostomatitis 85.7 7 
079.2 Coxsackie virus infection in conditions classified elsewhere 
and of unspecified site 
85.7 7 
711.06 Pyogenic arthritis, lower leg 85.7 7 
057.8 Other specified viral exanthemata 85 40 
041.49 Other and unspecified Escherichia coli [E. coli] 84.7 680 
041.4 Escherichia coli [E. coli] infection in conditions classified 
elsewhere and of unspecified site 
84.5 1393 
V29.0 Observation and evaluation of newborns and infants for 
suspected infectious condition 
84.4 1898 
320.9 Meningitis due to unspecified bacterium 84.4 64 
590.80 Pyelonephritis, unspecified 83.9 461 
038.9 Unspecified septicemia 83.9 199 
771.81 Septicemia [sepsis] of newborn 83.6 2638 
008.67 Enteritis due to enterovirus not elsewhere classified 83.3 12 
038.0 Streptococcal septicemia 83.3 12 
003.9 Salmonella infection, unspecified 83.3 6 
049.9 Unspecified non-arthropod-borne viral diseases of central 
nervous system 
83.3 6 
381.01 Acute serous otitis media 83.3 6 
488.12 Influenza due to identified novel H1N1 influenza virus with 
other respiratory manifestations 
83.3 6 
771.82 Urinary tract infection of newborn 82.6 2521 
320.82 Meningitis due to gram-negative bacteria, not elsewhere 
classified 
82.4 91 
054.3 Herpetic meningoencephalitis 82.1 56 
323.9 Unspecified causes of encephalitis, myelitis, and 
encephalomyelitis 
81.8 11 
595.9 Cystitis, unspecified 81.8 11 
778.4 Other disturbances of temperature regulation of newborn 80.7 13032 
041.02 Bacterial infection due to Streptococcus, group B 80.6 310 
995.91 Sepsis 80.4 107 
324.0 Intracranial abscess 80 10 
728.0 Infective myositis 80 10 
038.49 Other septicemia due to gram-negative organisms 80 5 
482.32 Pneumonia due to Streptococcus, group B 80 5 
730.28 Unspecified osteomyelitis, other specified sites 80 5 
995.90 Systemic inflammatory response syndrome, unspecified 80 5 
322.9 Meningitis, unspecified 79.5 302 
771.83 Bacteremia of newborn 79 538 
480.8 Pneumonia due to other virus not elsewhere classified 78.6 14 
487.8 Influenza with other manifestations 78.6 14 
599.0 Urinary tract infection, site not specified 78.5 432 
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
Appendix Table 1.1, continued 
 
790.8 Unspecified viremia 76.9 13 
785.50 Shock, unspecified 76.7 30 
041.04 Bacterial infection due to Streptococcus, group D 
[Enterococcus] 
76.5 311 
382.4 Unspecified suppurative otitis media 75 8 
033.1 Whooping cough due to Bordetella parapertussis [B. 
parapertussis] 
75 4 
038.11 Methicillin susceptible Staphylococcus aureus septicemia 75 4 
058.10 Roseola infantum, unspecified 75 4 
070.9 Unspecified viral hepatitis without mention of hepatic coma 75 4 
370.9 Unspecified keratitis 75 4 
730.26 Unspecified osteomyelitis, lower leg 75 4 
762.7 Chorioamnionitis affecting fetus or newborn 75 4 
770.0 Congenital pneumonia 74.6 189 
464.10 Acute tracheitis without mention of obstruction 74.4 43 
041.84 Bacterial infection due to other anaerobes 73.7 19 
325 Phlebitis and thrombophlebitis of intracranial venous sinuses 73.7 19 
054.72 Herpes simplex meningitis 73.3 30 
079.89 Other specified viral infection 73 806 
041.89 Bacterial infection due to other specified bacteria 73 122 
995.92 Severe sepsis 72.9 85 
790.7 Bacteremia 72.7 139 
711.05 Pyogenic arthritis, pelvic region and thigh 72.7 11 
041.85 Bacterial infection due to other gram-negative organisms 72.4 344 
078.89 Other specified diseases due to viruses 72.1 43 
041.3 Klebsiella pneumoniae infection in conditions classified 
elsewhere and of unspecified site 
72 214 
480.2 Pneumonia due to parainfluenza virus 71.4 14 
487.0 Influenza with pneumonia 71.4 14 
482.42 Methicillin resistant pneumonia due to Staphylococcus 
aureus 
71.4 7 
V09.1 Infection with microorganisms resistant to cephalosporins 
and other B-lactam antibiotics 
71.4 7 
041.6 Proteus (mirabilis) (morganii) infection in conditions 
classified elsewhere and of unspecified site 
70 30 
785.59 Other shock without mention of trauma 70 30 
041.7 Pseudomonas infection in conditions classified elsewhere 
and of unspecified site 
70 20 
785.52 Septic shock 69.2 78 
481 Pneumococcal pneumonia [Streptococcus pneumoniae 
pneumonia] 
69 29 
041.01 Bacterial infection due to Streptococcus, group A 67.9 56 
511.9 Unspecified pleural effusion 67.6 34 
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041.09 Bacterial infection due to other Streptococcus 66.7 102 
054.9 Herpes simplex without mention of complication 66.7 102 
527.2 Sialoadenitis 66.7 27 
008.43 Intestinal infection due to Campylobacter 66.7 12 
683 Acute lymphadenitis 66.7 12 
573.3 Hepatitis, unspecified 66.7 9 
V09.91 Infection with drug-resistant microorganisms, unspecified, 
with multiple drug resistance 
66.7 9 
996.62 Infection and inflammatory reaction due to other vascular 
device, implant, and graft 
66.7 6 
038.41 Septicemia due to Hemophilus influenzae [H. influenzae] 66.7 3 
041.05 Bacterial infection due to Streptococcus, group G 66.7 3 
058.29 Other human herpesvirus encephalitis 66.7 3 
372.20 Blepharoconjunctivitis, unspecified 66.7 3 
383.9 Unspecified mastoiditis 66.7 3 
480.0 Pneumonia due to adenovirus 66.7 3 
482.82 Pneumonia due to Escherichia coli [E. coli] 66.7 3 
528.09 Other stomatitis and mucositis (ulcerative) 66.7 3 
536.41 Infection of gastrostomy 66.7 3 
567.22 Peritoneal abscess 66.7 3 
573.1 Hepatitis in viral diseases classified elsewhere 66.7 3 
577.0 Acute pancreatitis 66.7 3 
590.2 Renal and perinephric abscess 66.7 3 
695.19 Other erythema multiforme 66.7 3 
711.02 Pyogenic arthritis, upper arm 66.7 3 
728.86 Necrotizing fasciitis 66.7 3 
730.20 Unspecified osteomyelitis, site unspecified 66.7 3 
916.3 Blister of hip, thigh, leg, and ankle, infected 66.7 3 
V09.3 Infection with microorganisms resistant to tetracyclines 66.7 3 
003.0 Salmonella gastroenteritis 65.8 38 
289.3 Lymphadenitis, unspecified, except mesenteric 65.6 32 
041.5 Hemophilus influenzae [H. influenzae] infection in 
conditions classified elsewhere and of unspecified site 
65.5 110 
079.0 Adenovirus infection in conditions classified elsewhere and 
of unspecified site 
65.4 26 
079.3 Rhinovirus infection in conditions classified elsewhere and 
of unspecified site 
65 712 
695.1 Erythema multiforme 65 20 
487.1 Influenza with other respiratory manifestations 64.4 637 
041.2 Pneumococcus infection in conditions classified elsewhere 
and of unspecified site 
64.3 28 
074.3 Hand, foot, and mouth disease 63.6 11 
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373.13 Abscess of eyelid 63.5 115 
008.61 Enteritis due to Rotavirus 63.3 79 
482.0 Pneumonia due to Klebsiella pneumoniae 62.5 8 
486 Pneumonia, organism unspecified 61.7 645 
780.6 Fever and other physiologic disturbances of temperature 
regulation 
60 1543 
098.40 Gonococcal conjunctivitis (neonatorum) 60 20 
090.1 Early congenital syphilis, latent 60 5 
488.82 Influenza due to identified novel influenza A virus with other 
respiratory manifestations 
59.1 22 
057.9 Viral exanthem, unspecified 58.9 236 
771.2 Other congenital infections specific to the perinatal period 58.7 436 
730.25 Unspecified osteomyelitis, pelvic region and thigh 57.1 7 
V09.2 Infection with microorganisms resistant to macrolides 57.1 7 
079.88 Other specified chlamydial infection 55.6 9 
604.90 Orchitis and epididymitis, unspecified 55.6 9 
616.10 Vaginitis and vulvovaginitis, unspecified 55.6 9 
482.2 Pneumonia due to Hemophilus influenzae [H. influenzae] 54.8 31 
682.0 Cellulitis and abscess of face 54.7 148 
041.00 Bacterial infection due to unspecified Streptococcus 54.2 24 
V09.0 Infection with microorganisms resistant to penicillins 53.8 238 
376.01 Orbital cellulitis 53.7 41 
041.12 Methicillin resistant Staphylococcus aureus in conditions 
classified elsewhere and of unspecified site 
52.9 427 
760.2 Maternal infections affecting fetus or newborn 52.6 57 
484.3 Pneumonia in whooping cough 52.6 19 
771.89 Other infections specific to the perinatal period 51.9 5500 
079.99 Unspecified viral infection 51.9 5267 
482.9 Bacterial pneumonia, unspecified 51.6 124 
041.19 Bacterial infection due to other Staphylococcus 51.2 203 
041.11 Methicillin susceptible Staphylococcus aureus in conditions 
classified elsewhere and of unspecified site 
51.1 820 
695.81 Ritter's disease 50.6 81 
041.9 Bacterial infection, unspecified, in conditions classified 
elsewhere and of unspecified site 
50 62 
682.7 Cellulitis and abscess of foot, except toes 50 22 
999.31 Infection due to central venous catheter 50 12 
V09.80 Infection with microorganisms resistant to other specified 
drugs without mention of resistance to multiple drugs 
50 12 
076.1 Trachoma, active stage 50 6 
077.8 Other viral conjunctivitis 50 4 
527.3 Abscess of salivary gland 50 4 
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597.89 Other urethritis 50 4 
038.19 Other staphylococcal septicemia 50 2 
076.9 Trachoma, unspecified 50 2 
078.5 Cytomegaloviral disease 50 2 
090.0 Early congenital syphilis, symptomatic 50 2 
372.04 Pseudomembranous conjunctivitis 50 2 
379.00 Scleritis, unspecified 50 2 
380.22 Other acute otitis externa 50 2 
461.0 Acute maxillary sinusitis 50 2 
46. Acute tonsillitis 50 2 
482.40 Pneumonia due to Staphylococcus, unspecified 50 2 
488.02 Influenza due to identified avian influenza virus with other 
respiratory manifestations 
50 2 
519.2 Mediastinitis 50 2 
595.0 Acute cystitis 50 2 
603.1 Infected hydrocele 50 2 
680.3 Carbuncle and furuncle of upper arm and forearm 50 2 
680.8 Carbuncle and furuncle of other specified sites 50 2 
711.04 Pyogenic arthritis, hand 50 2 
730.05 Acute osteomyelitis, pelvic region and thigh 50 2 
730.27 Unspecified osteomyelitis, ankle and foot 50 2 
771.3 Tetanus neonatorum 50 2 
996.64 Infection and inflammatory reaction due to indwelling 
urinary catheter 
50 2 
780.60 Fever, unspecified 47 4458 
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Appendix 2.1.  Simulation procedure for calculating difference-in-differences estimates  
 
After fitting a generalized linear model predicting expenditures, we set the vectors 
of coefficients and standard errors from the model to the parameters of a multivariate 
normal distribution.  In each of 1,000 simulation loops, we sampled coefficient values 
from this distribution.  Using these coefficients, we calculated the fitted values for each 
observation when 1) the indicators for post period and treatment group were set to 1 and 
the interaction term was set to 1, holding all other covariates constant; and 2) when the 
indicator for post period was set to 1, the indicator for treatment group was set to 0, and 
the interaction term was set to 0, holding all other covariates constant.  We transformed 
these fitted values to the dollar scale via exponentiation, then calculated their difference.  
We then repeated this procedure when: 1) the indicator for post period was set to 1, the 
indicator for treatment group were set to 0, and the interaction term was set to 0, holding 
all other covariates constant; and 2) when the indicators for post period and treatment 
group were set to 0 and the interaction term was set to 0, holding all other covariates 
constant.  The difference between these two differences was the difference-in-differences 
estimate for that observation.  The average of these estimates over all observations in the 
sample was the estimate of the difference-in-differences effect for the simulation loop.  
The mean and standard deviation of the 1,000 simulation estimates were the point 
estimate and standard error of the difference-in-differences estimate, respectively.  We 
calculated the p value based on a two-sided t-test with 999 degrees of freedom. 
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Appendix 2.2.  Adjustment for pre-existing trends  
 
 The regression specification for binary outcomes in the main analysis was: 
 
E(Yi)= β0 + β1*Treatmenti + β2*Posti + β3*Treatmenti*Posti + γ*Xi 
 
In this regression, Yi is the outcome for the ith observation, Posti is a binary 
variable that equals 1 if the ith observation came from 2011-2012, Treatmenti is a binary 
variable that equals 1 if the ith observation came from a young adult aged 19-25, and Xi 
is a vector of covariates.  
In a sensitivity analyses, we adjusted for pre-existing diverging trends by allowing 
for a differential slope and level change in the post period: 
E(Yi)= β0 + β1*Treatmenti + β2*Posti + β3*Treatmenti*Posti + β4*Datayeari  + β5*Datayeari *Treatmenti + 
β6*(Datayear-2002)i *Posti + β7*(Datayear-2002)i *Treatmenti * Posti +  γ*Xi 
 
 We then used Stata’s margins command to calculate a weighted average of the 
difference-in-differences effects in 2011 (differential level change plus the differential 
slope change) and 2012 (differential level change plus two times the differential slope 
change). 
 Results from trend-adjusted analyses are shown in Table 2.4.  For having health 
insurance coverage, having private health insurance coverage, and total annual out-of-
pocket expenditures, point estimates attenuated but remained statistically significant.  For 
self-reported physical health, and self-reported mental health, and percent of annual 
health care expenditures paid out-of-pocket, point estimates attenuated and lost statistical 
significance.  However, these estimates did not switch signs and suggested effects that 
were consistent with our conclusions.   
The trend-adjusted and non-trend-adjusted analyses likely represent reasonable 
bounds of the effect of the provision.  One reason to favor the trend-adjusted estimates 
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would be the existence of unobserved confounders differentially changing over time 
between comparison groups.  As discussed in the text, we did not find any evidence of 
large differential changes in observable characteristics, suggesting that there were no 
large differential changes in unobservable characteristics (Table 2.5).  Therefore, we 
presented the non-trend-adjusted analyses as the main results. 
  
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
APPENDIX FOR CHAPTER 3 
 
Table of Contents  
 
Appendix 3.1.  Specification and interpretation of linear regression models used for 
longitudinal comparisons 
 
Appendix 3.2.  Additional analyses addressing potential response bias 
 
Appendix Figure 3.1.  Changes in health insurance coverage, schooling, and adult 
presence at home among participants aged 14-25 with asthma, MEPS 1999-2009 
  
Dissertation Advisor: Professor B. Katherine Swartz                                   Kao-Ping Chua  
Appendix 3.1.  Specification and interpretation of linear regression models used for 
longitudinal comparisons 
 
In our longitudinal analyses, we fitted the following linear regression model: 
 
OUTCOMEiy = intercept + β1*YEAR2iy + β2*LOSSOFINSURANCEi  + 
β3*STOPSCHOOLi  + β4*LOSSOFADULTi + β5*LOSSOFINSURANCEi*YEAR2iy  + 
β6*STOPSCHOOLi*YEAR2iy +  β7*LOSSOFADULTi*YEAR2iy + covariates 
 
 In this model, OUTCOMEiy is the outcome for individual i in year y (1 or 2) and 
YEAR2iy is a dummy variable that indicates whether the data for individual i comes from 
year y (1 or 2).  LOSSOFINSURANCEi, STOPSCHOOLi, and LOSSOFADULTi are the 
predictor variables describing changes in insurance coverage, schooling, and adult 
presence at home between year 1 and year 2 for individual i.  Covariates include age 
dummies representing age in years at the beginning of MEPS participation, gender, race, 
region in year 1, residence in a Metropolitan Statistical Area in year 1, and data year 
(MEPS panel).  The following describes the interpretation of the coefficients of interest: 
 β1: The change in outcome between year 1 and year 2, in the absence of changes  in 
insurance coverage, schooling, or adult presence at home from year 1 to year 2. 
 β5: The additional/differential change in outcome in year 2 (relative to β1) that is 
associated with transitioning from continuous insurance coverage in year 1 to 
continuous uninsurance in year 2, controlling for changes in schooling and adult 
presence at home. 
 β6: The additional/differential change in outcome in year 2 (relative to β1) that is 
associated with transitioning from continuous full-time schooling in year 1 to no 
schooling in year 2, controlling for changes in insurance coverage and adult presence 
at home. 
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 β7: The additional/differential change in outcome in year 2 (relative to β1) that is 
associated with transitioning from continuous adult presence at home in year 1 to 
continuous independent living in year 2, controlling for changes in insurance 
coverage and schooling. 
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Appendix 3.2.  Additional analyses addressing potential response bias 
 One potential threat to our study is sample selection bias introduced by age-
related differences in responses to asthma-related questions, thereby leading to 
compositional differences between age groups in asthma severity and other unobserved 
factors.  However, the results of our cross-sectional analyses were consistent with the 
results of our longitudinal analyses, in which there was no age-related compositional 
change in the sample by definition. Thus, age-related compositional changes in our 
sample are unlikely to explain our findings.  In addition, we examined the age profile of 
asthma prevalence, using the definition of asthma from the cross-sectional analyses.  If 
there were differential entry into the sample because young adults with asthma were more 
or less likely to report asthma-related health care utilization or a current diagnosis of 
asthma, one would expect an abrupt change in asthma prevalence around age 18.  
However, as shown in the graph below, there is no evidence of such a change. 
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Appendix Figure 3.1.  Changes in health insurance coverage, schooling, and adult 
presence at home among participants aged 14-25 with asthma, MEPS 1999-2009.  
Student status information was only collected from participants aged 17-23 in the MEPS.  
To construct the graph of changes in schooling, we assumed that all participants aged 14-
16 were full-time students and excluded data from participants aged 24-25.  Using data 
from MEPS rounds 1-3 or 3-5, we classified participants as full-time students for all or 
most of the year if they were full-time students at the end of at least 2 of the 3 rounds.  
We applied similar criteria to identify participants with continuous adult presence at 
home for all or most of the year.  To classify the small number of participants with 
missing data for schooling or adult presence at home, we used the rounds for which data 
were available for these individuals.  The square data points represent excluded data for 
participants aged 18.  A) Percent of months with health insurance coverage; B) Percent of 
participants who were full-time students for all or most of the year; C) Percent of 
participants who had a continuous adult presence at home for all or most of the year.   
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